Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000350.3(ABCA4):c.[2588G>C;5603A>T]	ABCA4	G863A, N1868I	Stargardt disease 1	Likely pathogenic(Last reviewed: Jan 30, 2021)	criteria provided, single submitter	VCV001048132	1|1	94517254	1|1	94051698	1048132	22918|105279	rs76157638|rs1801466	NC_000001.11:94051697:C:G|NC_000001.11:94010910:T:A
NM_000350.2(ABCA4):c.[2588G>C;5153T>G]	ABCA4	G863A, V1718G	Stargardt disease 1	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000236092	1|1	94517254	1|1	94051698	236092	22918|237656	rs76157638|rs886044732	NC_000001.11:94051697:C:G|NC_000001.11:94019624:A:C
NM_000350.2(ABCA4):c.[2588G>C;3289A>T]	ABCA4	G863A, R1097*	Stargardt disease 1	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000236091	1|1	94517254	1|1	94051698	236091	22918|237681	rs76157638|rs886044731	NC_000001.11:94051697:C:G|NC_000001.11:94042799:T:A
NM_000350.2(ABCA4):c.2588G>C	ABCA4	G863A	Cone-rod dystrophy 3|Retinitis pigmentosa 19|Age-related macular degeneration|Age-related macular degeneration 2|not provided|Abnormal macular morphology|Peripheral neuropathy|Stargardt disease|Cone-rod dystrophy 3|Retinitis pigmentosa|Cone-rod dystrophy|Inborn genetic diseases|Retinal dystrophy|Stargardt disease 1|none provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2021)	criteria provided, conflicting interpretations	VCV000007879	1	94517254	1	94051698	7879	22918	rs76157638	NC_000001.11:94051697:C:G
NM_002025.4(AFF2):c.3623+57G>A	AFF2		FRAXE	Benign(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001188907	X	148062377	X	148980847	1188907	1179022		NC_000023.11:148980846:G:A
NM_002025.4(AFF2):c.1558-78G>C	AFF2		FRAXE	Benign(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001188906	X	148037055	X	148955525	1188906	1179021		NC_000023.11:148955524:G:C
NM_002025.4(AFF2):c.1041+56456A>G	AFF2	K15R	FRAXE	Benign(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001188905	X	147800748	X	148719224	1188905	1179020		NC_000023.11:148719223:A:G
NM_002025.4(AFF2):c.3448G>T (p.Asp1150Tyr)	AFF2	D1111Y, D1115Y, D1140Y, D1150Y, D791Y	FRAXE	Pathogenic(Last reviewed: Oct 16, 2018)	no assertion criteria provided	VCV000975105	X	148059506	X	148977976	975105	963397		NC_000023.11:148977975:G:T
NM_002025.4(AFF2):c.1173G>A (p.Gln391=)	AFF2		FRAXE|not specified	Uncertain significance(Last reviewed: Apr 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489209	X	147919257	X	148837733	489209	482239	rs929635504	NC_000023.11:148837732:G:A
NM_002025.4(AFF2):c.3267+5G>A	AFF2		not provided|FRAXE	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431909	X	148049227	X	148967697	431909	426411	rs374064624	NC_000023.11:148967696:G:A
NM_002025.4(AFF2):c.1842G>T (p.Leu614Phe)	AFF2	L614F, L579F, L604F, L575F, L581F, L255F	FRAXE|not provided	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000281219	X	148037417	X	148955887	281219	265456	rs371160275	NC_000023.11:148955886:G:T
NM_002025.4(AFF2):c.*4554C>G	AFF2		FRAXE	Uncertain significance	criteria provided, single submitter	VCV000219173	X	148077416	X	148995886	219173	217196	rs864321652	NC_000023.11:148995885:C:G
NM_002025.4(AFF2):c.2780G>A (p.Arg927His)	AFF2	R927H, R892H, R894H, R917H, R568H, R888H	not specified|FRAXE|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194202	X	148044334	X	148962804	194202	191365	rs140927355	NC_000023.11:148962803:G:A
NM_002025.4(AFF2):c.1830G>C (p.Leu610Phe)	AFF2	L610F, L577F, L575F, L251F, L571F, L600F	FRAXE|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000128283	X	148037405	X	148955875	128283	133732	rs200450195	NC_000023.11:148955874:G:C
NM_002025.4(AFF2):c.1488G>A (p.Ser496=)	AFF2		FRAXE|not specified|not provided	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128281	X	148035200	X	148953670	128281	133730	rs12011040	NC_000023.11:148953669:G:A
NM_002025.4(AFF2):c.3404+7A>G	AFF2		not specified|FRAXE	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000094028	X	148055144	X	148973614	94028	99930	rs5980615	NC_000023.11:148973613:A:G
NM_002025.4(AFF2):c.3088A>C (p.Ile1030Leu)	AFF2	I1030L, I671L, I1020L, I991L, I995L	Intellectual disability|FRAXE|not provided	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094027	X	148048494	X	148966964	94027	99929	rs149653283	NC_000023.11:148966963:A:C
NM_007294.4(BRCA1):c.5353C>T (p.Gln1785Ter)	BRCA1	Q1785*, Q681*, Q1738*, Q1806*	Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|Malignant tumor of breast|not provided|Breast-ovarian cancer, familial 1|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055546	17	41201191	17	43049174	55546	70213	rs80356969	NC_000017.11:43049173:G:A
NM_000064.4(C3):c.463A>C (p.Lys155Gln)	C3	K155Q	MACULAR DEGENERATION, AGE-RELATED, 9, SUSCEPTIBILITY TO|Atypical hemolytic-uremic syndrome 5|not provided|Complement component 3 deficiency, autosomal recessive|Age-related macular degeneration 9|not specified|Age-related macular degeneration 9|Atypical hemolytic-uremic syndrome 5|Complement component 3 deficiency, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000092162	19	6718146	19	6718135	92162	97565	rs147859257	NC_000019.10:6718134:T:G
NM_000186.4(CFH):c.3628C>T (p.Arg1210Cys)	CFH	R1210C	Basal laminar drusen|Age-related macular degeneration 4|Factor H deficiency|Atypical hemolytic-uremic syndrome 1|Atypical hemolytic-uremic syndrome 1|CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II|Factor H deficiency|Basal laminar drusen|not provided|Atypical hemolytic uremic syndrome|Age-related macular degeneration 4	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)	criteria provided, conflicting interpretations	VCV000016558	1	196716375	1	196747245	16558	31597	rs121913059	NC_000001.11:196747244:C:T
NM_000186.4(CFH):c.184G>A (p.Val62Ile)	CFH	V62I	Age-related macular degeneration 4|not provided|Basal laminar drusen|Factor H deficiency|Atypical hemolytic-uremic syndrome 1|CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016550	1	196642233	1	196673103	16550	31589	rs800292	NC_000001.11:196673102:G:A
NM_000186.4(CFH):c.1204= (p.His402=)	CFH		Age-related macular degeneration 4|Basal laminar drusen	Pathogenic, risk factor(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000016549	1	196659237	1	196690107	16549	31588	rs1061170	NC_000001.11:196690106:C:C
NM_017780.4(CHD7):c.1565G>T (p.Gly522Val)	CHD7	G522V	CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|History of neurodevelopmental disorder|not specified|not provided|Premature ovarian failure	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000241189	8	61655556	8	60742997	241189	240392	rs142962579	NC_000008.11:60742996:G:T
NM_007194.4(CHEK2):c.1169A>C (p.Tyr390Ser)	CHEK2	Y390S, Y433S, Y323S, Y361S, Y169S	Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Malignant tumor of breast|Hereditary breast and ovarian cancer syndrome|Premature ovarian failure	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2021)	criteria provided, conflicting interpretations	VCV000141818	22	29091788	22	28695800	141818	151532	rs200928781	NC_000022.11:28695799:T:G
NM_152524.5:c.1453_1454delGA,NM_012130.3:c.254T>A	CLDN14|SGO2	V85D, E485fs	Perrault syndrome	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000375673	21|2	37833740	21|2	36461442	375673	19890|362513	rs74315437|rs1057519602	NC_000021.9:36461441:A:T|NC_000002.12:200571795:AGAGA:AGA
NM_000088.4(COL1A1):c.2773C>G (p.Pro925Ala)	COL1A1	P925A	Ehlers-Danlos syndrome, classic type I|not provided|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001001743	17	48266794	17	50189433	1001743	997669		NC_000017.11:50189432:G:C
NM_000088.4(COL1A1):c.934C>T (p.Arg312Cys)	COL1A1	R312C	Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta with normal sclerae, dominant form|Bruising susceptibility|Fragile skin|Joint hypermobility	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017343	17	48273698	17	50196337	17343	32382	rs72645347	NC_000017.11:50196336:G:A
NM_000089.4(COL1A2):c.980G>A (p.Arg327His)	COL1A2	R327H	not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Feb 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV001020809	7	94039078	7	94409766	1020809	1007698		NC_000007.14:94409765:G:A
NM_000089.4(COL1A2):c.1331C>T (p.Pro444Leu)	COL1A2	P444L	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|not provided	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000952358	7	94040447	7	94411135	952358	924939		NC_000007.14:94411134:C:T
NM_000089.4(COL1A2):c.2465G>A (p.Arg822His)	COL1A2	R822H	not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000945199	7	94052330	7	94423018	945199	924947		NC_000007.14:94423017:G:A
NM_000089.4(COL1A2):c.2645G>A (p.Arg882His)	COL1A2	R882H	not provided|Ehlers-danlos syndrome, arthrochalasia type, 2|Ehlers-Danlos syndrome, cardiac valvular type|Osteogenesis imperfecta|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000843049	7	94053727	7	94424415	843049	833969		NC_000007.14:94424414:G:A
NM_000089.4(COL1A2):c.880G>T (p.Val294Phe)	COL1A2	V294F	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2020)	criteria provided, conflicting interpretations	VCV000772979	7	94038721	7	94409409	772979	700293	rs145693444	NC_000007.14:94409408:G:T
NM_000089.4(COL1A2):c.526T>C (p.Phe176Leu)	COL1A2	F176L	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|not provided|Osteogenesis imperfecta|Ehlers-danlos syndrome, arthrochalasia type, 2	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2020)	criteria provided, conflicting interpretations	VCV000707304	7	94035024	7	94405712	707304	692332	rs370234887	NC_000007.14:94405711:T:C
NM_000089.4(COL1A2):c.964G>A	COL1A2	G322S	Osteogenesis imperfecta|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta with normal sclerae, dominant form|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000618023	7	94039062	7	94409750	618023	609678	rs72656394	NC_000007.14:94409749:G:A
NM_000089.4(COL1A2):c.2968G>T (p.Ala990Ser)	COL1A2	A990S	not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000579371	7	94055334	7	94426022	579371	567262	rs367848162	NC_000007.14:94426021:G:T
NM_000089.4(COL1A2):c.949G>A (p.Val317Ile)	COL1A2	V317I	not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Dec 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000570172	7	94039047	7	94409735	570172	567247	rs142803502	NC_000007.14:94409734:G:A
NM_000089.4(COL1A2):c.1876G>A (p.Val626Met)	COL1A2	V626M	Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|not provided|Connective tissue disease	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561285	7	94047048	7	94417736	561285	552439	rs374878685	NC_000007.14:94417735:G:A
NM_000089.4(COL1A2):c.395G>A (p.Arg132His)	COL1A2	R132H	not provided|Connective tissue disease|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000547235	7	94034167	7	94404855	547235	537819	rs372678526	NC_000007.14:94404854:G:A
NM_000089.4(COL1A2):c.2717G>A (p.Arg906His)	COL1A2	R906H	not specified|not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487454	7	94054472	7	94425160	487454	480512	rs147063981	NC_000007.14:94425159:G:A
NM_000089.4(COL1A2):c.389G>A (p.Gly130Asp)	COL1A2	G130D	Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000456836	7	94034161	7	94404849	456836	457602	rs72656360	NC_000007.14:94404848:G:A
NM_000089.4(COL1A2):c.3209A>C (p.His1070Pro)	COL1A2	H1070P	Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000456828	7	94056549	7	94427237	456828	457090	rs767399660	NC_000007.14:94427236:A:C
NM_000089.4(COL1A2):c.2133+6T>A	COL1A2		Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta, recessive perinatal lethal	Pathogenic/Likely pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000456815	7	94049604	7	94420292	456815	457721	rs72658164	NC_000007.14:94420291:T:A
NM_000089.4(COL1A2):c.1072G>A (p.Gly358Ser)	COL1A2	G358S	not provided|Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta, recessive perinatal lethal	Pathogenic(Last reviewed: Jul 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000456802	7	94039590	7	94410278	456802	457708	rs66619856	NC_000007.14:94410277:G:A
NM_000089.4(COL1A2):c.2387G>C (p.Gly796Ala)	COL1A2	G796A	Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449351	7	94051248	7	94421936	449351	444186	rs72658189	NC_000007.14:94421935:G:C
NM_000089.4(COL1A2):c.767G>T (p.Gly256Val)	COL1A2	G256V	Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|not provided	Pathogenic(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000439504	7	94038110	7	94408798	439504	433414	rs67525025	NC_000007.14:94408797:G:T
NM_000089.4(COL1A2):c.1171G>A	COL1A2	G391S	not provided|Osteogenesis imperfecta with normal sclerae, dominant form|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Pathogenic(Last reviewed: Jun 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000425645	7	94039813	7	94410501	425645	413957	rs67707918	NC_000007.14:94410500:G:A
NM_000089.4(COL1A2):c.1009G>A (p.Gly337Ser)	COL1A2	G337S	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type III|Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta type III|not provided|Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Pathogenic(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000425643	7	94039107	7	94409795	425643	413955	rs67865220	NC_000007.14:94409794:G:A
NM_000089.4(COL1A2):c.2314G>A (p.Gly772Ser)	COL1A2	G772S	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|not provided|none provided	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420022	7	94050339	7	94421027	420022	407278	rs72658185	NC_000007.14:94421026:G:A
NM_000089.4(COL1A2):c.407G>A (p.Gly136Asp)	COL1A2	G136D	Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393233	7	94034179	7	94404867	393233	369673	rs1057524847	NC_000007.14:94404866:G:A
NM_000089.4(COL1A2):c.808G>A (p.Val270Ile)	COL1A2	V270I	Osteogenesis imperfecta|not provided|Ehlers-danlos syndrome, arthrochalasia type, 2|Connective tissue disease|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|none provided|not specified	Benign/Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000284986	7	94038649	7	94409337	284986	269223	rs368468	NC_000007.14:94409336:G:A
NM_000089.4(COL1A2):c.2957C>T (p.Pro986Leu)	COL1A2	P986L	not provided|Osteogenesis imperfecta type I|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta type III	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2021)	criteria provided, conflicting interpretations	VCV000216909	7	94055323	7	94426011	216909	213575	rs768171831	NC_000007.14:94426010:C:T
NM_000089.4(COL1A2):c.3034G>A (p.Gly1012Ser)	COL1A2	G1012S	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta|not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta type III|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta type III|Ehlers-danlos syndrome, arthrochalasia type, 2|Osteogenesis imperfecta, recessive perinatal lethal|Ehlers-Danlos syndrome, cardiac valvular type|Postmenopausal osteoporosis|Osteogenesis imperfecta with normal sclerae, dominant form	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000216908	7	94055771	7	94426459	216908	213576	rs72659319	NC_000007.14:94426458:G:A
NM_000089.4(COL1A2):c.838G>A (p.Gly280Ser)	COL1A2	G280S	not provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta	Pathogenic(Last reviewed: Dec 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000035957	7	94038679	7	94409367	35957	44621	rs72656387	NC_000007.14:94409366:G:A
NM_000089.4(COL1A2):c.1295G>A (p.Arg432Gln)	COL1A2	R432Q	not specified|not provided|Ehlers-Danlos syndrome, cardiac valvular type|Ehlers-danlos syndrome, arthrochalasia type, 2|Osteogenesis imperfecta type I|none provided|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Uncertain significance(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000035934	7	94040411	7	94411099	35934	44598	rs139446305	NC_000007.14:94411098:G:A
NM_000089.4(COL1A2):c.2251G>A (p.Gly751Ser)	COL1A2	G751S	Osteogenesis imperfecta type III|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000017267	7	94049916	7	94420604	17267	32306	rs72658176	NC_000007.14:94420603:G:A
NM_000089.4(COL1A2):c.2123G>A (p.Arg708Gln)	COL1A2	R708Q	Osteogenesis imperfecta|not provided|Ehlers-danlos syndrome, arthrochalasia type, 2|Connective tissue disease|Marfan syndrome, atypical|Postmenopausal osteoporosis|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2021)	criteria provided, conflicting interpretations	VCV000017250	7	94049588	7	94420276	17250	32289	rs72658163	NC_000007.14:94420275:G:A
NM_000090.4(COL3A1):c.3938A>G (p.Lys1313Arg)	COL3A1	K1313R	Ehlers-Danlos syndrome|not provided|Cardiovascular phenotype|Connective tissue disease|Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not specified|Ehlers-Danlos syndrome, type 4	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000161218	2	189875018	2	189010292	161218	171075	rs111840783	NC_000002.12:189010291:A:G
NM_000093.5(COL5A1):c.2677G>A (p.Ala893Thr)	COL5A1	A893T	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000834228	9	137681031	9	134789185	834228	835762		NC_000009.12:134789184:G:A
NM_000093.5(COL5A1):c.1832G>A (p.Arg611Gln)	COL5A1	R611Q	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000663129	9	137648615	9	134756769	663129	637960	rs200590188	NC_000009.12:134756768:G:A
NM_000093.5(COL5A1):c.4676A>C (p.His1559Pro)	COL5A1|LOC101448202	H1559P	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000662135	9	137715293	9	134823447	662135	637982	rs768691969	NC_000009.12:134823446:A:C
NM_000093.5(COL5A1):c.2390C>T (p.Ala797Val)	COL5A1	A797V	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jan 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000648784	9	137671952	9	134780106	648784	637967	rs745370910	NC_000009.12:134780105:C:T
NM_000093.5(COL5A1):c.3491C>T (p.Pro1164Leu)	COL5A1	P1164L	not provided|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2020)	criteria provided, conflicting interpretations	VCV000572790	9	137702117	9	134810271	572790	563720	rs368305377	NC_000009.12:134810270:C:T
NM_000093.5(COL5A1):c.4333C>T (p.Pro1445Ser)	COL5A1	P1445S	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000568806	9	137710604	9	134818758	568806	568793	rs757989702	NC_000009.12:134818757:C:T
NM_000093.5(COL5A1):c.3130G>A (p.Ala1044Thr)	COL5A1	A1044T	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000566208	9	137696836	9	134804990	566208	568784	rs370143255	NC_000009.12:134804989:G:A
NM_000093.5(COL5A1):c.2812G>C (p.Gly938Arg)	COL5A1	G938R	Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000529264	9	137688232	9	134796386	529264	524744	rs751950836	NC_000009.12:134796385:G:C
NM_000093.5(COL5A1):c.803G>T (p.Gly268Val)	COL5A1	G268V	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519661	9	137620532	9	134728686	519661	510012	rs145552797	NC_000009.12:134728685:G:T
NM_000093.5(COL5A1):c.5432C>T (p.Pro1811Leu)	COL5A1|LOC101448202	P1811L	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519660	9	137734064	9	134842218	519660	510039	rs1554727362	NC_000009.12:134842217:C:T
NM_000093.5(COL5A1):c.2543G>A (p.Arg848His)	COL5A1	R848H	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519654	9	137676893	9	134785047	519654	510025	rs767925708	NC_000009.12:134785046:G:A
NM_000093.5(COL5A1):c.1900G>A (p.Gly634Ser)	COL5A1	G634S	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519653	9	137650107	9	134758261	519653	510021	rs183627101	NC_000009.12:134758260:G:A
NM_000093.5(COL5A1):c.353C>G (p.Ser118Cys)	COL5A1	S118C	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519651	9	137591830	9	134699984	519651	510002	rs1554781494	NC_000009.12:134699983:C:G
NM_000093.5(COL5A1):c.3711C>T (p.Gly1237=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Sep 26, 2020)	criteria provided, conflicting interpretations	VCV000519648	9	137704315	9	134812469	519648	510030	rs763583510	NC_000009.12:134812468:C:T
NM_000093.5(COL5A1):c.628C>T (p.Arg210Trp)	COL5A1	R210W	Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000519647	9	137593153	9	134701307	519647	510006	rs1490728700	NC_000009.12:134701306:C:T
NM_000093.5(COL5A1):c.1304C>T (p.Pro435Leu)	COL5A1	P435L	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Mar 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519643	9	137623481	9	134731635	519643	510016	rs772379819	NC_000009.12:134731634:C:T
NM_000093.5(COL5A1):c.5389A>C (p.Lys1797Gln)	COL5A1|LOC101448202	K1797Q	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519642	9	137734021	9	134842175	519642	510038	rs560106611	NC_000009.12:134842174:A:C
NM_000093.5(COL5A1):c.753C>A (p.Thr251=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519636	9	137619210	9	134727364	519636	510009	rs374813957	NC_000009.12:134727363:C:A
NM_000093.5(COL5A1):c.446C>T (p.Pro149Leu)	COL5A1	P149L	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Feb 4, 2019)	criteria provided, conflicting interpretations	VCV000519635	9	137591923	9	134700077	519635	510004	rs369971694	NC_000009.12:134700076:C:T
NM_000093.5(COL5A1):c.354C>T (p.Ser118=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519629	9	137591831	9	134699985	519629	510003	rs748711211	NC_000009.12:134699984:C:T
NM_000093.5(COL5A1):c.3780C>T (p.Ser1260=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519628	9	137704486	9	134812640	519628	510031	rs150591401	NC_000009.12:134812639:C:T
NM_000093.5(COL5A1):c.4113C>T (p.Pro1371=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519627	9	137707825	9	134815979	519627	510033	rs143794669	NC_000009.12:134815978:C:T
NM_001278074.1(COL5A1):c.1780C>T (p.Arg594Ter)	COL5A1	R594*	not provided|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519624	9	137646125	9	134754279	519624	510020	rs1554792869	NC_000009.12:134754278:C:T
NM_000093.5(COL5A1):c.791C>T (p.Thr264Met)	COL5A1	T264M	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519623	9	137620520	9	134728674	519623	510011	rs148548209	NC_000009.12:134728673:C:T
NM_000093.5(COL5A1):c.3594C>T (p.Gly1198=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000519622	9	137703349	9	134811503	519622	510028	rs146176718	NC_000009.12:134811502:C:T
NM_000093.5(COL5A1):c.5436C>T (p.Ile1812=)	COL5A1|LOC101448202		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519621	9	137734068	9	134842222	519621	510040	rs140744620	NC_000009.12:134842221:C:T
NM_000093.5(COL5A1):c.1429G>A (p.Ala477Thr)	COL5A1	A477T	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000519570	9	137630359	9	134738513	519570	510018	rs774936702	NC_000009.12:134738512:G:A
NM_000093.5(COL5A1):c.615C>A (p.Ile205=)	COL5A1		Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Aug 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000517715	9	137593140	9	134701294	517715	502323	rs201286195	NC_000009.12:134701293:C:A
NM_000093.5(COL5A1):c.2751G>A (p.Pro917=)	COL5A1		Ehlers-Danlos syndrome, classic type|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516348	9	137687113	9	134795267	516348	502801	rs200319017	NC_000009.12:134795266:G:A
NM_000093.5(COL5A1):c.4536C>T (p.Ser1512=)	COL5A1|LOC101448202		Ehlers-Danlos syndrome, classic type|not provided|Cardiovascular phenotype	Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507841	9	137712051	9	134820205	507841	502700	rs367711669	NC_000009.12:134820204:C:T
NM_000093.5(COL5A1):c.735C>T (p.Asp245=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000459718	9	137619192	9	134727346	459718	459166	rs746769184	NC_000009.12:134727345:C:T
NM_000093.5(COL5A1):c.4607C>T (p.Pro1536Leu)	COL5A1|LOC101448202	P1536L	Ehlers-Danlos syndrome, classic type|Aneurysm of aortic root	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000459697	9	137713995	9	134822149	459697	459248	rs761837954	NC_000009.12:134822148:C:T
NM_000093.5(COL5A1):c.3812C>T (p.Pro1271Leu)	COL5A1	P1271L	Ehlers-Danlos syndrome, classic type|not provided|Abnormal bleeding	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000459682	9	137704518	9	134812672	459682	459194	rs771146636	NC_000009.12:134812671:C:T
NM_000093.5(COL5A1):c.3564C>A (p.Ile1188=)	COL5A1		Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000459678	9	137703220	9	134811374	459678	459184	rs766961124	NC_000009.12:134811373:C:A
NM_000093.5(COL5A1):c.3465C>T (p.Asp1155=)	COL5A1		Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000459675	9	137701127	9	134809281	459675	459651	rs145134399	NC_000009.12:134809280:C:T
NM_000093.5(COL5A1):c.3398G>A (p.Arg1133Gln)	COL5A1	R1133Q	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000459674	9	137701060	9	134809214	459674	459182	rs759580799	NC_000009.12:134809213:G:A
NM_000093.5(COL5A1):c.2184C>A (p.Ala728=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not specified	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000459661	9	137658896	9	134767050	459661	458782	rs150993138	NC_000009.12:134767049:C:A
NM_000093.5(COL5A1):c.1143C>T (p.Ala381=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I	Benign/Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459652	9	137622300	9	134730454	459652	458774	rs200245996	NC_000009.12:134730453:C:T
NM_000093.5(COL5A1):c.4048C>G (p.Pro1350Ala)	COL5A1	P1350A	Ehlers-Danlos syndrome, classic type|not specified	Uncertain significance(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000452990	9	137707455	9	134815609	452990	444400	rs762699995	NC_000009.12:134815608:C:G
NM_000093.5(COL5A1):c.4378C>A (p.Pro1460Thr)	COL5A1	P1460T	Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jun 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000451744	9	137710733	9	134818887	451744	444403	rs773125713	NC_000009.12:134818886:C:A
NM_000093.5(COL5A1):c.526A>C (p.Asn176His)	COL5A1	N176H	Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2020)	criteria provided, conflicting interpretations	VCV000451730	9	137593051	9	134701205	451730	444394	rs369396868	NC_000009.12:134701204:A:C
NM_000093.5(COL5A1):c.1307C>T (p.Ala436Val)	COL5A1	A436V	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not specified|not provided	Uncertain significance(Last reviewed: Apr 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000439538	9	137623484	9	134731638	439538	433443	rs144269434	NC_000009.12:134731637:C:T
NM_000093.5(COL5A1):c.4302C>T (p.Pro1434=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not specified|not provided	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000439534	9	137710573	9	134818727	439534	433439	rs755495352	NC_000009.12:134818726:C:T
NM_000093.5(COL5A1):c.2708C>T (p.Pro903Leu)	COL5A1	P903L	Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: May 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000430347	9	137686935	9	134795089	430347	421721	rs780406577	NC_000009.12:134795088:C:T
NM_000093.5(COL5A1):c.3551C>T (p.Pro1184Leu)	COL5A1	P1184L	Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426556	9	137703207	9	134811361	426556	415172	rs749093832	NC_000009.12:134811360:C:T
NM_000093.5(COL5A1):c.2983C>A (p.Pro995Thr)	COL5A1	P995T	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000424292	9	137693830	9	134801984	424292	407591	rs187022757	NC_000009.12:134801983:C:A
NM_000093.5(COL5A1):c.5311G>A (p.Asp1771Asn)	COL5A1|LOC101448202	D1771N	Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421939	9	137726991	9	134835145	421939	407601	rs1005244744	NC_000009.12:134835144:G:A
NM_000093.5(COL5A1):c.4910G>A (p.Arg1637His)	COL5A1|LOC101448202	R1637H	Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000419908	9	137716657	9	134824811	419908	407599	rs199998065	NC_000009.12:134824810:G:A
NM_000093.5(COL5A1):c.4121C>T (p.Thr1374Met)	COL5A1	T1374M	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2021)	criteria provided, conflicting interpretations	VCV000419573	9	137707833	9	134815987	419573	407595	rs151115748	NC_000009.12:134815986:C:T
NM_000093.5(COL5A1):c.2174A>G (p.Asn725Ser)	COL5A1	N725S	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000392843	9	137658886	9	134767040	392843	372466	rs142612655	NC_000009.12:134767039:A:G
NM_000093.5(COL5A1):c.1809C>T (p.Ala603=)	COL5A1		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000389153	9	137646154	9	134754308	389153	370022	rs371345820	NC_000009.12:134754307:C:T
NM_000093.5(COL5A1):c.363C>T (p.Asn121=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386768	9	137591840	9	134699994	386768	370525	rs369180922	NC_000009.12:134699993:C:T
NM_000093.5(COL5A1):c.12T>C (p.His4=)	COL5A1		not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000380649	9	137534045	9	134642199	380649	370812	rs368818087	NC_000009.12:134642198:T:C
NM_000093.5(COL5A1):c.4586C>A (p.Pro1529His)	COL5A1|LOC101448202	P1529H	not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jun 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000380308	9	137713974	9	134822128	380308	372545	rs201582108	NC_000009.12:134822127:C:A
NM_000093.5(COL5A1):c.5469G>C (p.Ala1823=)	COL5A1|LOC101448202		Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not provided	Benign/Likely benign(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000377729	9	137734101	9	134842255	377729	372549	rs367657505	NC_000009.12:134842254:G:C
NM_000093.5(COL5A1):c.2544C>A (p.Arg848=)	COL5A1		Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not specified	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377722	9	137676894	9	134785048	377722	372488	rs201556585	NC_000009.12:134785047:C:A
NM_000093.5(COL5A1):c.2983C>G (p.Pro995Ala)	COL5A1	P995A	not provided|not specified|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373323	9	137693830	9	134801984	373323	359913	rs187022757	NC_000009.12:134801983:C:G
NM_000093.5(COL5A1):c.2722C>T (p.Pro908Ser)	COL5A1	P908S	not provided|not specified|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373260	9	137686949	9	134795103	373260	359796	rs144985214	NC_000009.12:134795102:C:T
NM_000093.5(COL5A1):c.5293C>T (p.Arg1765Cys)	COL5A1|LOC101448202	R1765C	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome, type 7A	Uncertain significance(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000365734	9	137726973	9	134835127	365734	317318	rs199703883	NC_000009.12:134835126:C:T
NM_000093.5(COL5A1):c.3939G>T (p.Glu1313Asp)	COL5A1	E1313D	Ehlers-Danlos syndrome, type 7A|not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000365725	9	137706675	9	134814829	365725	307488	rs886063676	NC_000009.12:134814828:G:T
NM_000093.5(COL5A1):c.3897C>T (p.Gly1299=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2016)	criteria provided, conflicting interpretations	VCV000365723	9	137705873	9	134814027	365723	307475	rs745918663	NC_000009.12:134814026:C:T
NM_000093.5(COL5A1):c.3231A>G (p.Glu1077=)	COL5A1		Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2020)	criteria provided, conflicting interpretations	VCV000365719	9	137697033	9	134805187	365719	317695	rs376248130	NC_000009.12:134805186:A:G
NM_000093.5(COL5A1):c.2182G>A (p.Ala728Thr)	COL5A1	A728T	Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2020)	criteria provided, conflicting interpretations	VCV000365715	9	137658894	9	134767048	365715	311711	rs575535171	NC_000009.12:134767047:G:A
NM_000093.5(COL5A1):c.739G>A (p.Ala247Thr)	COL5A1	A247T	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome, type 7A	Uncertain significance(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000365707	9	137619196	9	134727350	365707	311704	rs769115550	NC_000009.12:134727349:G:A
NM_000093.5(COL5A1):c.37C>T (p.Leu13Phe)	COL5A1	L13F	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000365704	9	137534070	9	134642224	365704	317667	rs762625123	NC_000009.12:134642223:C:T
NM_000093.5(COL5A1):c.2088C>T (p.Pro696=)	COL5A1		Ehlers-Danlos syndrome, classic type|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2020)	criteria provided, conflicting interpretations	VCV000264547	9	137657580	9	134765734	264547	258530	rs146757272	NC_000009.12:134765733:C:T
NM_000093.5(COL5A1):c.3303C>T (p.Ile1101=)	COL5A1		Ehlers-Danlos syndrome, classic type|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264544	9	137698079	9	134806233	264544	258545	rs760754491	NC_000009.12:134806232:C:T
NM_000093.5(COL5A1):c.2991C>T (p.Gly997=)	COL5A1		Ehlers-Danlos syndrome, classic type|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2018)	criteria provided, conflicting interpretations	VCV000264527	9	137693838	9	134801992	264527	258542	rs766208976	NC_000009.12:134801991:C:T
NM_000093.5(COL5A1):c.3649C>T (p.Pro1217Ser)	COL5A1	P1217S	Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2019)	criteria provided, conflicting interpretations	VCV000264411	9	137703404	9	134811558	264411	258541	rs139116598	NC_000009.12:134811557:C:T
NM_000093.5(COL5A1):c.825C>T (p.Tyr275=)	COL5A1		Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000264205	9	137620554	9	134728708	264205	258526	rs771253587	NC_000009.12:134728707:C:T
NM_000093.5(COL5A1):c.3014C>T (p.Thr1005Met)	COL5A1	T1005M	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2020)	criteria provided, conflicting interpretations	VCV000264088	9	137694741	9	134802895	264088	258544	rs201220311	NC_000009.12:134802894:C:T
NM_000093.5(COL5A1):c.3087G>A (p.Pro1029=)	COL5A1		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000264078	9	137694814	9	134802968	264078	258533	rs774035950	NC_000009.12:134802967:G:A
NM_000093.5(COL5A1):c.1754C>T (p.Pro585Leu)	COL5A1	P585L	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264062	9	137645730	9	134753884	264062	258537	rs530442560	NC_000009.12:134753883:C:T
NM_000093.5(COL5A1):c.3428C>T (p.Pro1143Leu)	COL5A1	P1143L	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jun 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000264045	9	137701090	9	134809244	264045	258548	rs540131206	NC_000009.12:134809243:C:T
NM_000093.5(COL5A1):c.2238C>T (p.Pro746=)	COL5A1		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not specified	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264028	9	137660261	9	134768415	264028	258538	rs373617798	NC_000009.12:134768414:C:T
NM_000093.5(COL5A1):c.3987C>T (p.Pro1329=)	COL5A1		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264002	9	137706723	9	134814877	264002	258540	rs770802769	NC_000009.12:134814876:C:T
NM_000093.5(COL5A1):c.5280C>T (p.Tyr1760=)	COL5A1|LOC101448202		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000263994	9	137726960	9	134835114	263994	258549	rs767284056	NC_000009.12:134835113:C:T
NM_000093.5(COL5A1):c.295G>T (p.Asp99Tyr)	COL5A1	D99Y	Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000263968	9	137591772	9	134699926	263968	258532	rs774095835	NC_000009.12:134699925:G:T
NM_000093.5(COL5A1):c.1140C>T (p.Thr380=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Nov 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000263930	9	137622297	9	134730451	263930	258529	rs749315207	NC_000009.12:134730450:C:T
NM_000093.5(COL5A1):c.4968C>T (p.Val1656=)	COL5A1|LOC101448202		not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000255094	9	137717651	9	134825805	255094	253455	rs201871481	NC_000009.12:134825804:C:T
NM_000093.5(COL5A1):c.2493C>T (p.Ile831=)	COL5A1		not provided|not specified|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2019)	criteria provided, conflicting interpretations	VCV000255063	9	137676843	9	134784997	255063	253424	rs199630108	NC_000009.12:134784996:C:T
NM_000093.5(COL5A1):c.761C>T (p.Ser254Leu)	COL5A1	S254L	Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237008	9	137619218	9	134727372	237008	240514	rs144844792	NC_000009.12:134727371:C:T
NM_000093.5(COL5A1):c.4050C>T (p.Pro1350=)	COL5A1		Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000237002	9	137707457	9	134815611	237002	240521	rs773853291	NC_000009.12:134815610:C:T
NM_000093.5(COL5A1):c.2676C>A (p.Gly892=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2019)	criteria provided, conflicting interpretations	VCV000236999	9	137681030	9	134789184	236999	240518	rs143161140	NC_000009.12:134789183:C:A
NM_000093.5(COL5A1):c.597C>G (p.Ile199Met)	COL5A1	I199M	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213070	9	137593122	9	134701276	213070	209986	rs147008954	NC_000009.12:134701275:C:G
NM_000093.5(COL5A1):c.4906G>A (p.Ala1636Thr)	COL5A1|LOC101448202	A1636T	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2020)	criteria provided, conflicting interpretations	VCV000213062	9	137716653	9	134824807	213062	210131	rs113452150	NC_000009.12:134824806:G:A
NM_000093.5(COL5A1):c.4175G>A (p.Arg1392Lys)	COL5A1	R1392K	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213052	9	137708924	9	134817078	213052	210094	rs863223479	NC_000009.12:134817077:G:A
NM_000093.5(COL5A1):c.3418G>A (p.Val1140Met)	COL5A1	V1140M	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2021)	criteria provided, conflicting interpretations	VCV000213048	9	137701080	9	134809234	213048	210076	rs149616140	NC_000009.12:134809233:G:A
NM_000093.5(COL5A1):c.3023C>T (p.Thr1008Met)	COL5A1	T1008M	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Mar 26, 2021)	criteria provided, conflicting interpretations	VCV000213047	9	137694750	9	134802904	213047	210062	rs199735010	NC_000009.12:134802903:C:T
NM_000093.5(COL5A1):c.2894C>T (p.Pro965Leu)	COL5A1	P965L	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213046	9	137688743	9	134796897	213046	210058	rs376435205	NC_000009.12:134796896:C:T
NM_000093.5(COL5A1):c.2588A>T (p.Glu863Val)	COL5A1	E863V	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2021)	criteria provided, conflicting interpretations	VCV000213044	9	137676938	9	134785092	213044	210053	rs139788610	NC_000009.12:134785091:A:T
NM_000093.5(COL5A1):c.2555A>T (p.Asn852Ile)	COL5A1	N852I	Connective tissue disease|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213043	9	137676905	9	134785059	213043	210051	rs148146480	NC_000009.12:134785058:A:T
NM_000093.5(COL5A1):c.2281C>T (p.Pro761Ser)	COL5A1	P761S	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000213041	9	137660304	9	134768458	213041	210042	rs140486644	NC_000009.12:134768457:C:T
NM_000093.5(COL5A1):c.2096C>T (p.Thr699Met)	COL5A1	T699M	Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2021)	criteria provided, conflicting interpretations	VCV000213040	9	137658307	9	134766461	213040	210036	rs142313124	NC_000009.12:134766460:C:T
NM_000093.5(COL5A1):c.1970C>T (p.Pro657Leu)	COL5A1	P657L	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000213039	9	137653805	9	134761959	213039	210029	rs149912828	NC_000009.12:134761958:C:T
NM_000093.5(COL5A1):c.1388C>T (p.Pro463Leu)	COL5A1	P463L	not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213025	9	137623972	9	134732126	213025	210008	rs201375465	NC_000009.12:134732125:C:T
NM_000093.5(COL5A1):c.1351G>A (p.Glu451Lys)	COL5A1	E451K	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213024	9	137623935	9	134732089	213024	210007	rs755546104	NC_000009.12:134732088:G:A
NM_000093.5(COL5A1):c.1303C>G (p.Pro435Ala)	COL5A1	P435A	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Abnormal bleeding	Uncertain significance(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213021	9	137623480	9	134731634	213021	210003	rs377488010	NC_000009.12:134731633:C:G
NM_000093.5(COL5A1):c.944C>T (p.Thr315Met)	COL5A1	T315M	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000213018	9	137622101	9	134730255	213018	209994	rs145093766	NC_000009.12:134730254:C:T
NM_000093.5(COL5A1):c.754C>T (p.Pro252Ser)	COL5A1	P252S	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213017	9	137619211	9	134727365	213017	209989	rs369781295	NC_000009.12:134727364:C:T
NM_000093.5(COL5A1):c.598G>A (p.Asp200Asn)	COL5A1	D200N	Cardiovascular phenotype|not specified|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213015	9	137593123	9	134701277	213015	209987	rs142890619	NC_000009.12:134701276:G:A
NM_000093.5(COL5A1):c.367C>G (p.Gln123Glu)	COL5A1	Q123E	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2021)	criteria provided, conflicting interpretations	VCV000213011	9	137591844	9	134699998	213011	209979	rs142114921	NC_000009.12:134699997:C:G
NM_000093.5(COL5A1):c.341C>A (p.Ala114Asp)	COL5A1	A114D	Connective tissue disease|Cardiovascular phenotype|not specified|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213010	9	137591818	9	134699972	213010	209978	rs147589613	NC_000009.12:134699971:C:A
NM_000093.5(COL5A1):c.194G>A (p.Arg65Gln)	COL5A1	R65Q	Cardiovascular phenotype|not specified|not provided|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000213007	9	137582842	9	134690996	213007	209972	rs116003670	NC_000009.12:134690995:G:A
NM_000093.5(COL5A1):c.193C>T (p.Arg65Trp)	COL5A1	R65W	Connective tissue disease|Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213006	9	137582841	9	134690995	213006	209971	rs139468527	NC_000009.12:134690994:C:T
NM_000093.5(COL5A1):c.191C>T (p.Thr64Met)	COL5A1	T64M	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213005	9	137582839	9	134690993	213005	209970	rs777376620	NC_000009.12:134690992:C:T
NM_000093.5(COL5A1):c.145C>T (p.His49Tyr)	COL5A1	H49Y	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Abnormal bleeding|Thrombocytopenia	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213003	9	137582793	9	134690947	213003	209967	rs372168541	NC_000009.12:134690946:C:T
NM_000093.5(COL5A1):c.5182A>G (p.Met1728Val)	COL5A1|LOC101448202	M1728V	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212998	9	137726862	9	134835016	212998	210138	rs138068984	NC_000009.12:134835015:A:G
NM_000093.5(COL5A1):c.4643C>T (p.Ser1548Leu)	COL5A1|LOC101448202	S1548L	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2021)	criteria provided, conflicting interpretations	VCV000212984	9	137714878	9	134823032	212984	210113	rs147398633	NC_000009.12:134823031:C:T
NM_000093.5(COL5A1):c.4307C>T (p.Pro1436Leu)	COL5A1	P1436L	Connective tissue disease|Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Sep 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212977	9	137710578	9	134818732	212977	210100	rs752334702	NC_000009.12:134818731:C:T
NM_000093.5(COL5A1):c.4240G>A (p.Gly1414Ser)	COL5A1	G1414S	not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Mar 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212974	9	137710511	9	134818665	212974	210096	rs776709663	NC_000009.12:134818664:G:A
NM_000093.5(COL5A1):c.4162C>T (p.Pro1388Ser)	COL5A1	P1388S	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Aug 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212972	9	137708911	9	134817065	212972	210093	rs61737942	NC_000009.12:134817064:C:T
NM_000093.5(COL5A1):c.4066G>A (p.Ala1356Thr)	COL5A1	A1356T	not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212970	9	137707473	9	134815627	212970	210089	rs147868179	NC_000009.12:134815626:G:A
NM_000093.5(COL5A1):c.3983C>G (p.Pro1328Arg)	COL5A1	P1328R	Connective tissue disease|not provided|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Mar 24, 2020)	criteria provided, conflicting interpretations	VCV000212969	9	137706719	9	134814873	212969	210088	rs140797509	NC_000009.12:134814872:C:G
NM_000093.5(COL5A1):c.3868G>A (p.Ala1290Thr)	COL5A1	A1290T	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: May 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212967	9	137705844	9	134813998	212967	210083	rs863223451	NC_000009.12:134813997:G:A
NM_000093.5(COL5A1):c.3770G>A (p.Arg1257Gln)	COL5A1	R1257Q	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212965	9	137704476	9	134812630	212965	210079	rs141768094	NC_000009.12:134812629:G:A
NM_000093.5(COL5A1):c.3247C>T (p.Pro1083Ser)	COL5A1	P1083S	not provided|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212958	9	137697049	9	134805203	212958	210067	rs370321707	NC_000009.12:134805202:C:T
NM_000093.5(COL5A1):c.3236C>T (p.Pro1079Leu)	COL5A1	P1079L	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212957	9	137697038	9	134805192	212957	210066	rs863223447	NC_000009.12:134805191:C:T
NM_000093.5(COL5A1):c.3203T>G (p.Val1068Gly)	COL5A1	V1068G	not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jan 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212956	9	137696909	9	134805063	212956	210065	rs372109796	NC_000009.12:134805062:T:G
NM_000093.5(COL5A1):c.3110C>T (p.Thr1037Met)	COL5A1	T1037M	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212955	9	137694837	9	134802991	212955	210064	rs150487609	NC_000009.12:134802990:C:T
NM_000093.5(COL5A1):c.2947G>A (p.Glu983Lys)	COL5A1	E983K	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212952	9	137690302	9	134798456	212952	210059	rs146348246	NC_000009.12:134798455:G:A
NM_000093.5(COL5A1):c.2750C>T (p.Pro917Leu)	COL5A1	P917L	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212951	9	137687112	9	134795266	212951	210055	rs375600865	NC_000009.12:134795265:C:T
NM_000093.5(COL5A1):c.2564C>G (p.Pro855Arg)	COL5A1	P855R	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000212950	9	137676914	9	134785068	212950	210052	rs150539264	NC_000009.12:134785067:C:G
NM_000093.5(COL5A1):c.2354C>T (p.Pro785Leu)	COL5A1	P785L	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212949	9	137666727	9	134774881	212949	210046	rs760539229	NC_000009.12:134774880:C:T
NM_000093.5(COL5A1):c.2285C>T (p.Pro762Leu)	COL5A1	P762L	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Apr 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212948	9	137660308	9	134768462	212948	210043	rs138259992	NC_000009.12:134768461:C:T
NM_000093.5(COL5A1):c.2114C>T (p.Pro705Leu)	COL5A1	P705L	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212947	9	137658325	9	134766479	212947	210037	rs375456811	NC_000009.12:134766478:C:T
NM_000093.5(COL5A1):c.1888C>T (p.Arg630Trp)	COL5A1	R630W	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212944	9	137650095	9	134758249	212944	210026	rs577618553	NC_000009.12:134758248:C:T
NM_000093.5(COL5A1):c.1831C>T (p.Arg611Trp)	COL5A1	R611W	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212943	9	137648614	9	134756768	212943	210024	rs147329970	NC_000009.12:134756767:C:T
NM_000093.5(COL5A1):c.1805C>T (p.Pro602Leu)	COL5A1	P602L	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212942	9	137646150	9	134754304	212942	210023	rs749007253	NC_000009.12:134754303:C:T
NM_000093.5(COL5A1):c.1726C>T (p.Pro576Ser)	COL5A1	P576S	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212941	9	137645702	9	134753856	212941	210022	rs763246328	NC_000009.12:134753855:C:T
NM_000093.5(COL5A1):c.1637C>T (p.Ala546Val)	COL5A1	A546V	Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212937	9	137642703	9	134750857	212937	210018	rs557361751	NC_000009.12:134750856:C:T
NM_000093.5(COL5A1):c.1561A>G (p.Met521Val)	COL5A1	M521V	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Jul 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212935	9	137642454	9	134750608	212935	210014	rs535161301	NC_000009.12:134750607:A:G
NM_000093.5(COL5A1):c.1507C>T (p.Arg503Cys)	COL5A1	R503C	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212932	9	137642400	9	134750554	212932	210011	rs781485753	NC_000009.12:134750553:C:T
NM_000093.5(COL5A1):c.61C>T (p.Pro21Ser)	COL5A1	P21S	Connective tissue disease|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212930	9	137534094	9	134642248	212930	209962	rs548525119	NC_000009.12:134642247:C:T
NM_000093.5(COL5A1):c.1350C>T (p.Gly450=)	COL5A1		Connective tissue disease|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000212929	9	137623934	9	134732088	212929	210006	rs576332528	NC_000009.12:134732087:C:T
NM_000093.5(COL5A1):c.1281G>A (p.Pro427=)	COL5A1		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome, classic type I	Benign/Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212927	9	137623458	9	134731612	212927	210000	rs147292897	NC_000009.12:134731611:G:A
NM_000093.5(COL5A1):c.1158C>T (p.Ser386=)	COL5A1		Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212926	9	137622315	9	134730469	212926	209998	rs61729497	NC_000009.12:134730468:C:T
NM_000093.5(COL5A1):c.1077G>A (p.Glu359=)	COL5A1		Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212925	9	137622234	9	134730388	212925	209996	rs201166370	NC_000009.12:134730387:G:A
NM_000093.5(COL5A1):c.996C>T (p.Asp332=)	COL5A1		Connective tissue disease|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212924	9	137622153	9	134730307	212924	209995	rs144763302	NC_000009.12:134730306:C:T
NM_000093.5(COL5A1):c.934C>G (p.Pro312Ala)	COL5A1	P312A	Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2020)	criteria provided, conflicting interpretations	VCV000212923	9	137622091	9	134730245	212923	209993	rs140105243	NC_000009.12:134730244:C:G
NM_000093.5(COL5A1):c.804C>T (p.Gly268=)	COL5A1		Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000212921	9	137620533	9	134728687	212921	209991	rs147729713	NC_000009.12:134728686:C:T
NM_000093.5(COL5A1):c.514G>A (p.Val172Ile)	COL5A1	V172I	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212919	9	137593039	9	134701193	212919	209985	rs150147262	NC_000009.12:134701192:G:A
NM_000093.5(COL5A1):c.279G>A (p.Ala93=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212917	9	137591756	9	134699910	212917	209974	rs145090868	NC_000009.12:134699909:G:A
NM_000093.5(COL5A1):c.278C>T (p.Ala93Val)	COL5A1	A93V	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not specified|Ehlers-Danlos syndrome, type 7A|not provided	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212916	9	137591755	9	134699909	212916	209973	rs41306397	NC_000009.12:134699908:C:T
NM_000093.5(COL5A1):c.126C>T (p.Leu42=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, classic type I|not specified|Ehlers-Danlos syndrome, type 7A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000212915	9	137582774	9	134690928	212915	209966	rs149369116	NC_000009.12:134690927:C:T
NM_000093.5(COL5A1):c.5154C>T (p.Ala1718=)	COL5A1|LOC101448202		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212910	9	137726834	9	134834988	212910	210137	rs147434147	NC_000009.12:134834987:C:T
NM_000093.5(COL5A1):c.4788G>C (p.Gly1596=)	COL5A1|LOC101448202		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome, classic type I	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212909	9	137716535	9	134824689	212909	210122	rs138436047	NC_000009.12:134824688:G:C
NM_000093.5(COL5A1):c.3905C>T (p.Pro1302Leu)	COL5A1	P1302L	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000212902	9	137705881	9	134814035	212902	210084	rs201920777	NC_000009.12:134814034:C:T
NM_000093.5(COL5A1):c.3291C>T (p.Ala1097=)	COL5A1		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212898	9	137698067	9	134806221	212898	210069	rs371821655	NC_000009.12:134806220:C:T
NM_000093.5(COL5A1):c.2310T>A (p.Pro770=)	COL5A1		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212893	9	137664659	9	134772813	212893	210044	rs377123592	NC_000009.12:134772812:T:A
NM_000093.5(COL5A1):c.2268C>T (p.Pro756=)	COL5A1		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212892	9	137660291	9	134768445	212892	210041	rs367755808	NC_000009.12:134768444:C:T
NM_000093.5(COL5A1):c.2058G>A (p.Pro686=)	COL5A1		Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212890	9	137657550	9	134765704	212890	210035	rs143443499	NC_000009.12:134765703:G:A
NM_000093.5(COL5A1):c.2031G>A (p.Glu677=)	COL5A1		Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212889	9	137655580	9	134763734	212889	210032	rs61737719	NC_000009.12:134763733:G:A
NM_000093.5(COL5A1):c.1953C>T (p.Ser651=)	COL5A1		Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212886	9	137653788	9	134761942	212886	210028	rs78215347	NC_000009.12:134761941:C:T
NM_000093.5(COL5A1):c.1383C>T (p.Ile461=)	COL5A1		Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not specified|Ehlers-Danlos syndrome, type 7A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000198991	9	137623967	9	134732121	198991	196151	rs61736827	NC_000009.12:134732120:C:T
NM_000093.5(COL5A1):c.805G>A (p.Glu269Lys)	COL5A1	E269K	Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2020)	criteria provided, conflicting interpretations	VCV000198041	9	137620534	9	134728688	198041	195202	rs761079177	NC_000009.12:134728687:G:A
NM_000093.5(COL5A1):c.4234G>A (p.Glu1412Lys)	COL5A1	E1412K	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000197977	9	137710505	9	134818659	197977	195138	rs376893441	NC_000009.12:134818658:G:A
NM_000093.5(COL5A1):c.3204+3G>A	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, classic type I|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2021)	criteria provided, conflicting interpretations	VCV000197404	9	137696913	9	134805067	197404	194565	rs202054108	NC_000009.12:134805066:G:A
NM_000093.5(COL5A1):c.2695G>A (p.Gly899Ser)	COL5A1	G899S	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000196728	9	137681049	9	134789203	196728	193889	rs149964491	NC_000009.12:134789202:G:A
NM_000093.5(COL5A1):c.240C>T (p.Asp80=)	COL5A1		Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A|not specified	Benign/Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195014	9	137582888	9	134691042	195014	192176	rs79724538	NC_000009.12:134691041:C:T
NM_000093.5(COL5A1):c.5350G>A (p.Ala1784Thr)	COL5A1|LOC101448202	A1784T	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided|Familial thoracic aortic aneurysm and aortic dissection|Connective tissue disease	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2021)	criteria provided, conflicting interpretations	VCV000180300	9	137727030	9	134835184	180300	178596	rs143859495	NC_000009.12:134835183:G:A
NM_000093.5(COL5A1):c.514G>T (p.Val172Phe)	COL5A1	V172F	Aortic valve disease 1|Familial thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Connective tissue disease	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2021)	criteria provided, conflicting interpretations	VCV000180298	9	137593039	9	134701193	180298	178594	rs150147262	NC_000009.12:134701192:G:T
NM_000093.5(COL5A1):c.1432-5T>C	COL5A1		FIBROMUSCULAR DYSPLASIA, MULTIFOCAL|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A|not specified|not provided	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136931	9	137630587	9	134738741	136931	140634	rs3128612	NC_000009.12:134738740:T:C
NM_000093.5(COL5A1):c.1431G>A (p.Ala477=)	COL5A1		not provided|Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136930	9	137630361	9	134738515	136930	140633	rs61729545	NC_000009.12:134738514:G:A
NM_000093.5(COL5A1):c.1092C>T (p.Pro364=)	COL5A1		Ehlers-Danlos syndrome, classic type I|not specified|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not provided	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136927	9	137622249	9	134730403	136927	140630	rs41306391	NC_000009.12:134730402:C:T
NM_000093.5(COL5A1):c.1062C>T (p.Asp354=)	COL5A1		Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136926	9	137622219	9	134730373	136926	140629	rs61737708	NC_000009.12:134730372:C:T
NM_000093.5(COL5A1):c.738C>T (p.Thr246=)	COL5A1		Ehlers-Danlos syndrome, classic type I|not specified|Ehlers-Danlos syndrome, type 7A|not provided|FIBROMUSCULAR DYSPLASIA, MULTIFOCAL|Cardiovascular phenotype	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136922	9	137619195	9	134727349	136922	140625	rs3124299	NC_000009.12:134727348:C:T
NM_000093.5(COL5A1):c.574G>A (p.Asp192Asn)	COL5A1	D192N	Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|not provided|not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136920	9	137593099	9	134701253	136920	140623	rs138579182	NC_000009.12:134701252:G:A
NM_000093.5(COL5A1):c.573C>T (p.Leu191=)	COL5A1		not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136919	9	137593098	9	134701252	136919	140622	rs116715381	NC_000009.12:134701251:C:T
NM_000093.5(COL5A1):c.378G>T (p.Gln126His)	COL5A1	Q126H	not specified|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136918	9	137591855	9	134700009	136918	140621	rs145178917	NC_000009.12:134700008:G:T
NM_000093.5(COL5A1):c.252C>T (p.Ser84=)	COL5A1		not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136917	9	137582900	9	134691054	136917	140620	rs151293601	NC_000009.12:134691053:C:T
NM_000093.5(COL5A1):c.5407G>A (p.Asp1803Asn)	COL5A1|LOC101448202	D1803N	Ehlers-Danlos syndrome, classic type I|not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136915	9	137734039	9	134842193	136915	140618	rs61729495	NC_000009.12:134842192:G:A
NM_000093.5(COL5A1):c.5270C>T (p.Thr1757Met)	COL5A1|LOC101448202	T1757M	not provided|Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136914	9	137726950	9	134835104	136914	140617	rs2229817	NC_000009.12:134835103:C:T
NM_000093.5(COL5A1):c.5190C>T (p.Phe1730=)	COL5A1|LOC101448202		Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136912	9	137726870	9	134835024	136912	140615	rs61729481	NC_000009.12:134835023:C:T
NM_000093.5(COL5A1):c.5151C>T (p.Asp1717=)	COL5A1|LOC101448202		not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136911	9	137726831	9	134834985	136911	140614	rs61729558	NC_000009.12:134834984:C:T
NM_000093.5(COL5A1):c.5034G>A (p.Ser1678=)	COL5A1|LOC101448202		not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136906	9	137717717	9	134825871	136906	140609	rs148006741	NC_000009.12:134825870:G:A
NM_000093.5(COL5A1):c.4560C>T (p.Ile1520=)	COL5A1|LOC101448202		not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|not provided	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136901	9	137713948	9	134822102	136901	140604	rs2228559	NC_000009.12:134822101:C:T
NM_000093.5(COL5A1):c.4482G>C (p.Pro1494=)	COL5A1|LOC101448202		not provided|FIBROMUSCULAR DYSPLASIA, MULTIFOCAL|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136900	9	137711997	9	134820151	136900	140603	rs2228560	NC_000009.12:134820150:G:C
NM_000093.5(COL5A1):c.4482G>A (p.Pro1494=)	COL5A1|LOC101448202		not specified|Ehlers-Danlos syndrome, type 7A|not provided|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136899	9	137711997	9	134820151	136899	140602	rs2228560	NC_000009.12:134820150:G:A
NM_000093.5(COL5A1):c.4410C>T (p.Pro1470=)	COL5A1		Connective tissue disease|not provided|Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000136898	9	137710863	9	134819017	136898	140601	rs41310953	NC_000009.12:134819016:C:T
NM_000093.5(COL5A1):c.4383C>T (p.Pro1461=)	COL5A1		not specified|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136895	9	137710738	9	134818892	136895	140598	rs368551709	NC_000009.12:134818891:C:T
NM_000093.5(COL5A1):c.4230+5C>T	COL5A1		Connective tissue disease|Familial thoracic aortic aneurysm and aortic dissection|not specified|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136892	9	137709682	9	134817836	136892	140595	rs142248898	NC_000009.12:134817835:C:T
NM_000093.5(COL5A1):c.4135C>T (p.Pro1379Ser)	COL5A1	P1379S	Ehlers-Danlos syndrome, type 7A|not provided|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not specified	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136890	9	137708884	9	134817038	136890	140593	rs61739195	NC_000009.12:134817037:C:T
NM_000093.5(COL5A1):c.4122G>A (p.Thr1374=)	COL5A1		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not specified|Ehlers-Danlos syndrome, type 7A|not provided	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136889	9	137707834	9	134815988	136889	140592	rs3827848	NC_000009.12:134815987:G:A
NM_000093.5(COL5A1):c.4065C>T (p.Pro1355=)	COL5A1		not specified|Connective tissue disease|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136887	9	137707472	9	134815626	136887	140590	rs61737906	NC_000009.12:134815625:C:T
NM_000093.5(COL5A1):c.3888G>A (p.Pro1296=)	COL5A1		not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Sep 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136883	9	137705864	9	134814018	136883	140586	rs375631252	NC_000009.12:134814017:G:A
NM_000093.5(COL5A1):c.3855C>T (p.Gly1285=)	COL5A1		Ehlers-Danlos syndrome, classic type I|not specified|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136882	9	137705831	9	134813985	136882	140585	rs139544503	NC_000009.12:134813984:C:T
NM_000093.5(COL5A1):c.3591C>T (p.Asp1197=)	COL5A1		not specified|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000136880	9	137703346	9	134811500	136880	140583	rs370349155	NC_000009.12:134811499:C:T
NM_000093.5(COL5A1):c.2892C>T (p.Gly964=)	COL5A1		not specified|not provided|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136876	9	137688741	9	134796895	136876	140579	rs78511105	NC_000009.12:134796894:C:T
NM_000093.5(COL5A1):c.2852A>G (p.Asn951Ser)	COL5A1	N951S	not specified|Ehlers-Danlos syndrome, type 7A|not provided|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136875	9	137688701	9	134796855	136875	140578	rs61736966	NC_000009.12:134796854:A:G
NM_000093.5(COL5A1):c.2799+4T>C	COL5A1		not specified|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136871	9	137687165	9	134795319	136871	140574	rs75815945	NC_000009.12:134795318:T:C
NM_000093.5(COL5A1):c.2724G>A (p.Pro908=)	COL5A1		Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136869	9	137686951	9	134795105	136869	140572	rs41310207	NC_000009.12:134795104:G:A
NM_000093.5(COL5A1):c.2439C>T (p.Asp813=)	COL5A1		not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136867	9	137674521	9	134782675	136867	140570	rs148648778	NC_000009.12:134782674:C:T
NM_000093.5(COL5A1):c.1566G>A (p.Leu522=)	COL5A1		Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|not specified	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136860	9	137642459	9	134750613	136860	140563	rs61737941	NC_000009.12:134750612:G:A
NM_000093.5(COL5A1):c.1539C>T (p.Pro513=)	COL5A1		not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136859	9	137642432	9	134750586	136859	140562	rs151173863	NC_000009.12:134750585:C:T
NM_000093.5(COL5A1):c.1588G>A (p.Gly530Ser)	COL5A1	G530S	not specified|Ehlers-Danlos syndrome, classic type I|not provided|Connective tissue disease|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000038863	9	137642654	9	134750808	38863	47468	rs61735045	NC_000009.12:134750807:G:A
NM_000093.5(COL5A1):c.3906+3G>T	COL5A1		not provided|Ehlers-Danlos syndrome, classic type I	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000017183	9	137705885	9	134814039	17183	32222	rs786200922	NC_000009.12:134814038:G:T
NM_000393.5(COL5A2):c.1351T>C (p.Ser451Pro)	COL5A2	S451P	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519688	2	189932791	2	189068065	519688	509483	rs548441536	NC_000002.12:189068064:A:G
NM_000393.5(COL5A2):c.2712G>A (p.Pro904=)	COL5A2		Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not provided	Benign/Likely benign(Last reviewed: Jul 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000519687	2	189917478	2	189052752	519687	509475	rs372869641	NC_000002.12:189052751:C:T
NM_000393.5(COL5A2):c.3582G>A (p.Gly1194=)	COL5A2		Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Likely benign(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519686	2	189906363	2	189041637	519686	509467	rs140022057	NC_000002.12:189041636:C:T
NM_000393.5(COL5A2):c.586G>C (p.Ala196Pro)	COL5A2	A196P	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519683	2	189953480	2	189088754	519683	509485	rs142855115	NC_000002.12:189088753:C:G
NM_000393.5(COL5A2):c.288T>C (p.Cys96=)	COL5A2		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519681	2	189974985	2	189110259	519681	509488	rs577308799	NC_000002.12:189110258:A:G
NM_000393.5(COL5A2):c.4096A>G (p.Met1366Val)	COL5A2	M1366V	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519680	2	189901359	2	189036633	519680	509463	rs372226064	NC_000002.12:189036632:T:C
NM_000393.5(COL5A2):c.3848G>A (p.Arg1283His)	COL5A2	R1283H	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519679	2	189904075	2	189039349	519679	509465	rs747653593	NC_000002.12:189039348:C:T
NM_000393.5(COL5A2):c.3646G>A (p.Glu1216Lys)	COL5A2	E1216K	Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519677	2	189904277	2	189039551	519677	509466	rs755429175	NC_000002.12:189039550:C:T
NM_000393.5(COL5A2):c.250G>A (p.Asp84Asn)	COL5A2	D84N	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519674	2	189975023	2	189110297	519674	509489	rs745528957	NC_000002.12:189110296:C:T
NM_000393.5(COL5A2):c.2002C>A (p.Gln668Lys)	COL5A2	Q668K	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Aug 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000519672	2	189926317	2	189061591	519672	509479	rs144652675	NC_000002.12:189061590:G:T
NM_000393.5(COL5A2):c.3246G>C (p.Gln1082His)	COL5A2	Q1082H	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000519669	2	189910589	2	189045863	519669	509470	rs1039715132	NC_000002.12:189045862:C:G
NM_000393.5(COL5A2):c.2846C>G (p.Ser949Cys)	COL5A2	S949C	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2020)	criteria provided, conflicting interpretations	VCV000519666	2	189916131	2	189051405	519666	509473	rs201961021	NC_000002.12:189051404:G:C
NM_000393.5(COL5A2):c.2882C>T (p.Pro961Leu)	COL5A2	P961L	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2020)	criteria provided, conflicting interpretations	VCV000519663	2	189916095	2	189051369	519663	509471	rs778835151	NC_000002.12:189051368:G:A
NM_000393.5(COL5A2):c.3855C>T (p.Pro1285=)	COL5A2		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000508973	2	189904068	2	189039342	508973	499671	rs199904322	NC_000002.12:189039341:G:A
NM_000393.5(COL5A2):c.1776G>A (p.Ala592=)	COL5A2		Ehlers-Danlos syndrome, classic type|not provided|Cardiovascular phenotype|not specified	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000508176	2	189927991	2	189063265	508176	499836	rs773332771	NC_000002.12:189063264:C:T
NM_000393.5(COL5A2):c.3676C>T (p.Pro1226Ser)	COL5A2	P1226S	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000459746	2	189904247	2	189039521	459746	450138	rs199621926	NC_000002.12:189039520:G:A
NM_000393.5(COL5A2):c.3422A>C (p.Gln1141Pro)	COL5A2	Q1141P	not provided|Familial aortopathy|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426754	2	189907926	2	189043200	426754	414860	rs144890303	NC_000002.12:189043199:T:G
NM_000393.5(COL5A2):c.2104G>A (p.Gly702Arg)	COL5A2	G702R	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421973	2	189923601	2	189058875	421973	405516	rs772811492	NC_000002.12:189058874:C:T
NM_000393.5(COL5A2):c.379A>G (p.Ile127Val)	COL5A2	I127V	Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421503	2	189963476	2	189098750	421503	405522	rs1064795177	NC_000002.12:189098749:T:C
NM_000393.5(COL5A2):c.3488A>G (p.Gln1163Arg)	COL5A2	Q1163R	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000408279	2	189907483	2	189042757	408279	392444	rs758412337	NC_000002.12:189042756:T:C
NM_000393.5(COL5A2):c.2839C>A (p.Pro947Thr)	COL5A2	P947T	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000393071	2	189916138	2	189051412	393071	365964	rs1027615025	NC_000002.12:189051411:G:T
NM_000393.5(COL5A2):c.1228C>T (p.Pro410Ser)	COL5A2	P410S	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000392252	2	189933541	2	189068815	392252	366224	rs1042644306	NC_000002.12:189068814:G:A
NM_000393.5(COL5A2):c.1A>G (p.Met1Val)	COL5A2	M1V	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided|Ehlers-Danlos syndrome classic type 2|Connective tissue disease|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Aug 26, 2021)	criteria provided, conflicting interpretations	VCV000391833	2	190044330	2	189179604	391833	366013	rs563606558	NC_000002.12:189179603:T:C
NM_000393.5(COL5A2):c.3373G>A (p.Gly1125Arg)	COL5A2	G1125R	Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2018)	criteria provided, conflicting interpretations	VCV000382848	2	189907975	2	189043249	382848	366218	rs151187317	NC_000002.12:189043248:C:T
NM_000393.5(COL5A2):c.4443T>C (p.Asp1481=)	COL5A2		Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: Dec 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377738	2	189898853	2	189034127	377738	366219	rs142857608	NC_000002.12:189034126:A:G
NM_000393.5(COL5A2):c.1017A>C (p.Gly339=)	COL5A2		Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2020)	criteria provided, conflicting interpretations	VCV000377732	2	189943284	2	189078558	377732	366226	rs140609193	NC_000002.12:189078557:T:G
NM_000393.5(COL5A2):c.851C>T (p.Pro284Leu)	COL5A2	P284L	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000333147	2	189948711	2	189083985	333147	286579	rs540573303	NC_000002.12:189083984:G:A
NM_000393.5(COL5A2):c.2544C>T (p.Ala848=)	COL5A2		Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2020)	criteria provided, conflicting interpretations	VCV000333140	2	189918159	2	189053433	333140	286241	rs370774253	NC_000002.12:189053432:G:A
NM_000393.5(COL5A2):c.3614T>C (p.Val1205Ala)	COL5A2	V1205A	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000333134	2	189906331	2	189041605	333134	283566	rs148110552	NC_000002.12:189041604:A:G
NM_000393.5(COL5A2):c.2627G>A (p.Gly876Glu)	COL5A2	G876E	not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	VCV000265645	2	189917671	2	189052945	265645	259715	rs886039694	NC_000002.12:189052944:C:T
NM_000393.5(COL5A2):c.2988C>T (p.Gly996=)	COL5A2		Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2019)	criteria provided, conflicting interpretations	VCV000264616	2	189915346	2	189050620	264616	258233	rs201299226	NC_000002.12:189050619:G:A
NM_000393.5(COL5A2):c.3222G>A (p.Gly1074=)	COL5A2		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000264502	2	189910613	2	189045887	264502	258231	rs149574060	NC_000002.12:189045886:C:T
NM_000393.5(COL5A2):c.4409C>T (p.Ala1470Val)	COL5A2	A1470V	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	VCV000264358	2	189898887	2	189034161	264358	258234	rs140109751	NC_000002.12:189034160:G:A
NM_000393.5(COL5A2):c.2884C>A (p.Pro962Thr)	COL5A2	P962T	Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2018)	criteria provided, conflicting interpretations	VCV000263921	2	189916093	2	189051367	263921	258235	rs754018138	NC_000002.12:189051366:G:T
NM_000393.5(COL5A2):c.403-3T>C	COL5A2		Ehlers-Danlos syndrome, type 7A|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000256003	2	189962059	2	189097333	256003	250467	rs369733690	NC_000002.12:189097332:A:G
NM_000393.5(COL5A2):c.2492G>C (p.Gly831Ala)	COL5A2	G831A	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2020)	criteria provided, conflicting interpretations	VCV000255998	2	189918628	2	189053902	255998	250460	rs141210030	NC_000002.12:189053901:C:G
NM_000393.5(COL5A2):c.750G>A (p.Pro250=)	COL5A2		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I|not specified	Benign/Likely benign(Last reviewed: Sep 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000237779	2	189949934	2	189085208	237779	238585	rs751819198	NC_000002.12:189085207:C:T
NM_000393.5(COL5A2):c.4470C>T (p.Gly1490=)	COL5A2		Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|not provided	Likely benign(Last reviewed: May 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000237778	2	189898826	2	189034100	237778	238580	rs142895373	NC_000002.12:189034099:G:A
NM_000393.5(COL5A2):c.3913G>A (p.Ala1305Thr)	COL5A2	A1305T	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000237776	2	189904010	2	189039284	237776	238582	rs372897632	NC_000002.12:189039283:C:T
NM_000393.5(COL5A2):c.437G>A (p.Arg146Gln)	COL5A2	R146Q	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213161	2	189962022	2	189097296	213161	209569	rs144430633	NC_000002.12:189097295:C:T
NM_000393.5(COL5A2):c.3316C>T (p.Arg1106Trp)	COL5A2	R1106W	Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A|not provided|Ehlers-Danlos syndrome, classic type I|Connective tissue disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000213156	2	189909952	2	189045226	213156	209518	rs146789395	NC_000002.12:189045225:G:A
NM_000393.5(COL5A2):c.3170C>A (p.Thr1057Asn)	COL5A2	T1057N	not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000213154	2	189912966	2	189048240	213154	209523	rs201186702	NC_000002.12:189048239:G:T
NM_000393.5(COL5A2):c.34C>T (p.Leu12Phe)	COL5A2	L12F	not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000213139	2	190044297	2	189179571	213139	209579	rs768807471	NC_000002.12:189179570:G:A
NM_000393.5(COL5A2):c.5T>C (p.Met2Thr)	COL5A2	M2T	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213138	2	190044326	2	189179600	213138	209581	rs762874073	NC_000002.12:189179599:A:G
NM_000393.5(COL5A2):c.4451G>A (p.Gly1484Asp)	COL5A2	G1484D	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213132	2	189898845	2	189034119	213132	209494	rs761481937	NC_000002.12:189034118:C:T
NM_000393.5(COL5A2):c.4358G>A (p.Arg1453Gln)	COL5A2	R1453Q	Ehlers-Danlos syndrome, classic type|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2020)	criteria provided, conflicting interpretations	VCV000213130	2	189898938	2	189034212	213130	209497	rs149064715	NC_000002.12:189034211:C:T
NM_000393.5(COL5A2):c.4295A>T (p.Asp1432Val)	COL5A2	D1432V	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|not specified	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213128	2	189899700	2	189034974	213128	209499	rs141777954	NC_000002.12:189034973:T:A
NM_000393.5(COL5A2):c.4240G>A (p.Asp1414Asn)	COL5A2	D1414N	not specified|Connective tissue disease|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213127	2	189899755	2	189035029	213127	209500	rs139229616	NC_000002.12:189035028:C:T
NM_000393.5(COL5A2):c.3385G>A (p.Asp1129Asn)	COL5A2	D1129N	not provided|Connective tissue disease|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2021)	criteria provided, conflicting interpretations	VCV000213117	2	189907963	2	189043237	213117	209517	rs199802059	NC_000002.12:189043236:C:T
NM_000393.5(COL5A2):c.3178C>T (p.Arg1060Trp)	COL5A2	R1060W	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213114	2	189912958	2	189048232	213114	209522	rs374549843	NC_000002.12:189048231:G:A
NM_000393.5(COL5A2):c.2648C>A (p.Ser883Tyr)	COL5A2	S883Y	not provided|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213109	2	189917650	2	189052924	213109	209535	rs773515722	NC_000002.12:189052923:G:T
NM_000393.5(COL5A2):c.2533G>A (p.Val845Ile)	COL5A2	V845I	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Dec 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000213107	2	189918170	2	189053444	213107	209538	rs375124784	NC_000002.12:189053443:C:T
NM_000393.5(COL5A2):c.2291C>G (p.Pro764Arg)	COL5A2	P764R	Connective tissue disease|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I|not provided|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2020)	criteria provided, conflicting interpretations	VCV000213106	2	189922092	2	189057366	213106	209541	rs150260969	NC_000002.12:189057365:G:C
NM_000393.5(COL5A2):c.1633C>T (p.Arg545Trp)	COL5A2	R545W	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2020)	criteria provided, conflicting interpretations	VCV000213099	2	189929366	2	189064640	213099	209555	rs145258293	NC_000002.12:189064639:G:A
NM_000393.5(COL5A2):c.1621G>T (p.Ala541Ser)	COL5A2	A541S	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Uncertain significance(Last reviewed: Mar 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000213098	2	189929378	2	189064652	213098	209556	rs768348357	NC_000002.12:189064651:C:A
NM_000393.5(COL5A2):c.2741C>T (p.Ala914Val)	COL5A2	A914V	Ehlers-Danlos syndrome, type 7A|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000213092	2	189916926	2	189052200	213092	209533	rs201486858	NC_000002.12:189052199:G:A
NM_000393.5(COL5A2):c.75A>G (p.Lys25=)	COL5A2		Ehlers-Danlos syndrome classic type 2|not specified|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000213090	2	190044256	2	189179530	213090	209578	rs549894501	NC_000002.12:189179529:T:C
NM_000393.5(COL5A2):c.33C>T (p.Leu11=)	COL5A2		Ehlers-Danlos syndrome classic type 2|not specified|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213089	2	190044298	2	189179572	213089	209580	rs140108893	NC_000002.12:189179571:G:A
NM_000393.5(COL5A2):c.4495G>T (p.Val1499Leu)	COL5A2	V1499L	Connective tissue disease|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2021)	criteria provided, conflicting interpretations	VCV000213087	2	189898801	2	189034075	213087	209493	rs527433112	NC_000002.12:189034074:C:A
NM_000393.5(COL5A2):c.4450G>A (p.Gly1484Ser)	COL5A2	G1484S	not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2020)	criteria provided, conflicting interpretations	VCV000213086	2	189898846	2	189034120	213086	209495	rs147420365	NC_000002.12:189034119:C:T
NM_000393.5(COL5A2):c.4197G>A (p.Gln1399=)	COL5A2		Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|not specified	Benign/Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213085	2	189899798	2	189035072	213085	209501	rs78870279	NC_000002.12:189035071:C:T
NM_000393.5(COL5A2):c.4173C>G (p.Arg1391=)	COL5A2		not specified|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type I	Conflicting interpretations of pathogenicity(Last reviewed: Aug 20, 2020)	criteria provided, conflicting interpretations	VCV000213084	2	189899822	2	189035096	213084	209502	rs148590409	NC_000002.12:189035095:G:C
NM_000393.5(COL5A2):c.2716-4C>T	COL5A2		Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|not specified	Benign(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213079	2	189916955	2	189052229	213079	209534	rs111644889	NC_000002.12:189052228:G:A
NM_000393.5(COL5A2):c.1454C>A (p.Pro485Gln)	COL5A2	P485Q	Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type I|not provided|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000213074	2	189931456	2	189066730	213074	209560	rs145281966	NC_000002.12:189066729:G:T
NM_000393.5(COL5A2):c.1301C>T (p.Thr434Met)	COL5A2	T434M	Connective tissue disease|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212979	2	189932953	2	189068227	212979	209562	rs145850743	NC_000002.12:189068226:G:A
NM_000393.5(COL5A2):c.3794A>G (p.Asp1265Gly)	COL5A2	D1265G	Cardiovascular phenotype|Marfan syndrome|Ehlers-Danlos syndrome classic type 2|not provided|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2020)	criteria provided, conflicting interpretations	VCV000180305	2	189904129	2	189039403	180305	178495	rs200325397	NC_000002.12:189039402:T:C
NM_000393.5(COL5A2):c.1976C>T (p.Pro659Leu)	COL5A2	P659L	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not specified|Connective tissue disease|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2021)	criteria provided, conflicting interpretations	VCV000155777	2	189927592	2	189062866	155777	165529	rs145404046	NC_000002.12:189062865:G:A
NM_000393.5(COL5A2):c.261G>A (p.Thr87=)	COL5A2		not provided|not specified|Ehlers-Danlos syndrome, classic type I|Connective tissue disease|Ehlers-Danlos syndrome, type 7A|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136963	2	189975012	2	189110286	136963	140666	rs142044596	NC_000002.12:189110285:C:T
NM_000393.5(COL5A2):c.249C>T (p.Ala83=)	COL5A2		not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136962	2	189975024	2	189110298	136962	140665	rs142388534	NC_000002.12:189110297:G:A
NM_000393.5(COL5A2):c.198T>C (p.Asn66=)	COL5A2		Connective tissue disease|Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136961	2	189975075	2	189110349	136961	140664	rs76511879	NC_000002.12:189110348:A:G
NM_000393.5(COL5A2):c.4449C>T (p.Gly1483=)	COL5A2		Ehlers-Danlos syndrome classic type 2|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136959	2	189898847	2	189034121	136959	140662	rs78905646	NC_000002.12:189034120:G:A
NM_000393.5(COL5A2):c.4392T>C (p.Tyr1464=)	COL5A2		not specified|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000136958	2	189898904	2	189034178	136958	140661	rs142544320	NC_000002.12:189034177:A:G
NM_000393.5(COL5A2):c.4389A>G (p.Glu1463=)	COL5A2		Connective tissue disease|Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136957	2	189898907	2	189034181	136957	140660	rs146100075	NC_000002.12:189034180:T:C
NM_000393.5(COL5A2):c.3837T>C (p.Ile1279=)	COL5A2		not specified|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Benign/Likely benign(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136955	2	189904086	2	189039360	136955	140658	rs148795690	NC_000002.12:189039359:A:G
NM_000393.5(COL5A2):c.3720T>C (p.Tyr1240=)	COL5A2		Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136954	2	189904203	2	189039477	136954	140657	rs10208525	NC_000002.12:189039476:A:G
NM_000393.5(COL5A2):c.3690A>C (p.Thr1230=)	COL5A2		not provided|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136953	2	189904233	2	189039507	136953	140656	rs10197596	NC_000002.12:189039506:T:G
NM_000393.5(COL5A2):c.3689C>G (p.Thr1230Arg)	COL5A2	T1230R	Ehlers-Danlos syndrome classic type 2|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136952	2	189904234	2	189039508	136952	140655	rs62184175	NC_000002.12:189039507:G:C
NM_000393.5(COL5A2):c.3098C>T (p.Pro1033Leu)	COL5A2	P1033L	Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136949	2	189914122	2	189049396	136949	140652	rs75542756	NC_000002.12:189049395:G:A
NM_000393.5(COL5A2):c.2867G>C (p.Arg956Pro)	COL5A2	R956P	not specified|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000136948	2	189916110	2	189051384	136948	140651	rs6434313	NC_000002.12:189051383:C:G
NM_000393.5(COL5A2):c.2562C>T (p.Asp854=)	COL5A2		Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Connective tissue disease|not provided|Cardiovascular phenotype|not specified|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136946	2	189917736	2	189053010	136946	140649	rs148430780	NC_000002.12:189053009:G:A
NM_000393.5(COL5A2):c.2498C>T (p.Pro833Leu)	COL5A2	P833L	Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|not provided|Cardiovascular phenotype|not specified	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136944	2	189918622	2	189053896	136944	140647	rs116298748	NC_000002.12:189053895:G:A
NM_000393.5(COL5A2):c.1535T>C (p.Val512Ala)	COL5A2	V512A	not provided|not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136941	2	189931144	2	189066418	136941	140644	rs35852101	NC_000002.12:189066417:A:G
NM_000393.5(COL5A2):c.1400C>T (p.Pro467Leu)	COL5A2	P467L	Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A|not specified	Benign/Likely benign(Last reviewed: Apr 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136940	2	189932742	2	189068016	136940	140643	rs115570272	NC_000002.12:189068015:G:A
NM_000393.5(COL5A2):c.1378C>T (p.Pro460Ser)	COL5A2	P460S	not specified|Ehlers-Danlos syndrome, type 7A|not provided|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136939	2	189932764	2	189068038	136939	140642	rs35830636	NC_000002.12:189068037:G:A
NM_000393.5(COL5A2):c.1182G>A (p.Ala394=)	COL5A2		Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Connective tissue disease|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|not specified	Benign/Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136937	2	189933587	2	189068861	136937	140640	rs148229627	NC_000002.12:189068860:C:T
NM_000393.5(COL5A2):c.1081A>C (p.Met361Leu)	COL5A2	M361L	Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, type 7A|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136935	2	189940142	2	189075416	136935	140638	rs76148000	NC_000002.12:189075415:T:G
NM_000393.5(COL5A2):c.1035G>C (p.Gly345=)	COL5A2		Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136934	2	189943266	2	189078540	136934	140637	rs148786600	NC_000002.12:189078539:C:G
NM_000393.5(COL5A2):c.975C>T (p.Pro325=)	COL5A2		Ehlers-Danlos syndrome, type 7A|not specified|Ehlers-Danlos syndrome, classic type I|Ehlers-Danlos syndrome classic type 2|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136932	2	189943819	2	189079093	136932	140635	rs144344474	NC_000002.12:189079092:G:A
NM_001360.3(DHCR7):c.199G>A (p.Ala67Thr)	DHCR7	A67T	History of neurodevelopmental disorder|Smith-Lemli-Opitz syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2021)	criteria provided, conflicting interpretations	VCV000093714	11	71155161	11	71444115	93714	99617	rs143999854	NC_000011.10:71444114:C:T
NM_001360.3(DHCR7):c.452G>A (p.Trp151Ter)	DHCR7	W151*	2-3 toe syndactyly|Congenital microcephaly|Small for gestational age|Elevated 7-dehydrocholesterol|Smith-Lemli-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000021273	11	71152447	11	71441401	21273	34125	rs11555217	NC_000011.10:71441400:C:T
NM_000124.4(ERCC6):c.595C>G (p.Leu199Val)	ERCC6|ERCC6-PGBD3	L199V	Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300093	10	50736520	10	49528474	300093	321580	rs886047039	NC_000010.11:49528473:G:C
NM_000124.4(ERCC6):c.1062T>C (p.Pro354=)	ERCC6|ERCC6-PGBD3		Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided|Age-related macular degeneration 5|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000300090	10	50732414	10	49524368	300090	315583	rs764159237	NC_000010.11:49524367:A:G
NM_000124.4(ERCC6):c.1280T>C (p.Phe427Ser)	ERCC6|ERCC6-PGBD3|PGBD3	F427S	Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Cockayne syndrome B|Age-related macular degeneration 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300082	10	50732196	10	49524150	300082	310452	rs886047038	NC_000010.11:49524149:A:G
NM_000124.4(ERCC6):c.1482C>T (p.Asp494=)	ERCC6		Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|not provided|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000300078	10	50713974	10	49505928	300078	310447	rs150762517	NC_000010.11:49505927:G:A
NM_000124.4(ERCC6):c.2696C>T (p.Thr899Met)	ERCC6	T899M	Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Cerebrooculofacioskeletal syndrome 1	Uncertain significance(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300061	10	50681536	10	49473490	300061	322307	rs374470147	NC_000010.11:49473489:G:A
NM_000124.4(ERCC6):c.2974C>G (p.Gln992Glu)	ERCC6	Q992E	DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5|Cockayne syndrome B	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000300056	10	50679117	10	49471071	300056	315553	rs772104945	NC_000010.11:49471070:G:C
NM_000124.4(ERCC6):c.3453A>G (p.Leu1151=)	ERCC6		Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Age-related macular degeneration 5	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000300050	10	50678553	10	49470507	300050	310422	rs771604820	NC_000010.11:49470506:T:C
NM_000124.4(ERCC6):c.3480C>G (p.Pro1160=)	ERCC6		Age-related macular degeneration 5|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000300048	10	50678526	10	49470480	300048	321541	rs886047034	NC_000010.11:49470479:G:C
NM_000124.4(ERCC6):c.4186A>G (p.Arg1396Gly)	ERCC6	R1396G	DE SANCTIS-CACCHIONE SYNDROME|Premature ovarian failure 11|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|Age-related macular degeneration 5|Lung carcinoma|UV-sensitive syndrome 1|not specified|DE SANCTIS-CACCHIONE SYNDROME|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190173	10	50667157	10	49459111	190173	187986	rs745352643	NC_000010.11:49459110:T:C
NM_000124.4(ERCC6):c.1357C>T (p.Arg453Ter)	ERCC6|PGBD3|ERCC6-PGBD3	R453*	not provided|Cockayne syndrome B|Cerebrooculofacioskeletal syndrome 1|Cockayne syndrome B|DE SANCTIS-CACCHIONE SYNDROME|UV-sensitive syndrome 1|Cerebrooculofacioskeletal syndrome 1|Premature ovarian failure 11|Age-related macular degeneration 5|Cockayne syndrome B|Lung carcinoma|DE SANCTIS-CACCHIONE SYNDROME	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001703	10	50732119	10	49524073	1703	16742	rs121917902	NC_000010.11:49524072:G:A
NM_001999.4(FBN2):c.8082C>A (p.His2694Gln)	FBN2	H2694Q	Congenital contractural arachnodactyly|none provided|Cardiovascular phenotype|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)	criteria provided, conflicting interpretations	VCV000213254	5	127599227	5	128263535	213254	209661	rs142755118	NC_000005.10:128263534:G:T
NM_001110556.2(FLNA):c.6532G>C (p.Val2178Leu)	FLNA	V2178L, V2170L	Ehlers-Danlos syndrome	Uncertain significance(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000625275	X	153580786	X	154352418	625275	613502	rs1569551461	NC_000023.11:154352417:C:G
NM_001110556.2(FLNA):c.4528A>C (p.Asn1510His)	FLNA	N1510H	Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000492840	X	153586883	X	154358515	492840	485814	rs1557177310	NC_000023.11:154358514:T:G
NM_002024.6(FMR1):c.797G>A (p.Gly266Glu)	FMR1	G266E	History of neurodevelopmental disorder	Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000590253	X	147014110	X	147932591	590253	580945	rs1569545763	NC_000023.11:147932590:G:A
NM_002024.6(FMR1):c.818A>G (p.Lys273Arg)	FMR1	K273R	Fragile X syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2018)	criteria provided, conflicting interpretations	VCV000444826	X	147014220	X	147932701	444826	438466	rs139029212	NC_000023.11:147932700:A:G
NM_002024.6(FMR1):c.1572C>T (p.Ser524=)	FMR1	A434V, A413V	History of neurodevelopmental disorder|Fragile X syndrome|not provided|not specified	Benign/Likely benign(Last reviewed: Jun 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000211027	X	147026489	X	147944969	211027	208890	rs143889976	NC_000023.11:147944968:C:T
NM_002024.6(FMR1):c.433G>T (p.Ala145Ser)	FMR1	A145S	History of neurodevelopmental disorder|Fragile X syndrome|not specified	Benign(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000129104	X	147011480	X	147929961	129104	134550	rs29281	NC_000023.11:147929960:G:T
NM_002024.6(FMR1):c.414G>A (p.Arg138=)	FMR1		not provided|Fragile X syndrome|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000094023	X	147010320	X	147928802	94023	99925	rs25707	NC_000023.11:147928801:G:A
NM_002024.6(FMR1):c.80C>A (p.Ser27Ter)	FMR1	S27*	Fragile X syndrome	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000029987	X	147003479	X	147921961	29987	38942	rs1569545382	NC_000023.11:147921960:C:A
NM_002024.6(FMR1):c.911T>A (p.Ile304Asn)	FMR1	I304N	Fragile X syndrome	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000009969	X	147018053	X	147936534	9969	25008	rs121434622	NC_000023.11:147936533:T:A
NM_002049.4(GATA1):c.598+3G>A	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Nov 15, 2020)	criteria provided, single submitter	VCV001169017	X	48650631	X	48792224	1169017	1159687		NC_000023.11:48792223:G:A
NM_002049.4(GATA1):c.594C>A (p.Pro198=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001168149	X	48650624	X	48792217	1168149	1159686		NC_000023.11:48792216:C:A
NM_002049.4(GATA1):c.1208C>T (p.Thr403Ile)	GATA1	T403I	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001168062	X	48652537	X	48794130	1168062	1159693		NC_000023.11:48794129:C:T
NM_002049.4(GATA1):c.173C>T (p.Ala58Val)	GATA1	A58V	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001167646	X	48649689	X	48791282	1167646	1159685		NC_000023.11:48791281:C:T
NM_002049.4(GATA1):c.1170C>G (p.Pro390=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001167511	X	48652499	X	48794092	1167511	1159691		NC_000023.11:48794091:C:G
NM_002049.4(GATA1):c.1176C>G (p.Gly392=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001166965	X	48652505	X	48794098	1166965	1159692		NC_000023.11:48794097:C:G
NM_002049.4(GATA1):c.678C>T (p.Asn226=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV001166816	X	48650809	X	48792402	1166816	1159689		NC_000023.11:48792401:C:T
NM_002049.4(GATA1):c.600G>A (p.Glu200=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV001165472	X	48650731	X	48792324	1165472	1159688		NC_000023.11:48792323:G:A
NM_002049.4(GATA1):c.1157T>C (p.Leu386Pro)	GATA1	L386P	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001165471	X	48652486	X	48794079	1165471	1159690		NC_000023.11:48794078:T:C
NM_002049.4(GATA1):c.192G>A (p.Arg64=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, single submitter	VCV001156597	X	48649708	X	48791301	1156597	1150823		NC_000023.11:48791300:G:A
NM_002049.4(GATA1):c.147C>A (p.Ala49=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV001153013	X	48649663	X	48791256	1153013	1150822		NC_000023.11:48791255:C:A
NM_002049.4(GATA1):c.740G>A (p.Arg247His)	GATA1	R247H	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001133049	X	48650871	X	48792464	1133049	1129806		NC_000023.11:48792463:G:A
NM_002049.4(GATA1):c.534C>A (p.Ser178Arg)	GATA1	S178R	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001132744	X	48650564	X	48792157	1132744	1129805		NC_000023.11:48792156:C:A
NM_002049.4(GATA1):c.1041G>A (p.Gly347=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001117385	X	48652370	X	48793963	1117385	1108423		NC_000023.11:48793962:G:A
NM_002049.4(GATA1):c.220+10T>C	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV001116465	X	48649746	X	48791339	1116465	1108422		NC_000023.11:48791338:T:C
NM_002049.4(GATA1):c.360C>T (p.Ala120=)	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001088052	X	48650390	X	48791983	1088052	1086720		NC_000023.11:48791982:C:T
NM_002049.4(GATA1):c.3G>T (p.Met1Ile)	GATA1	M1I	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001068653	X	48649519	X	48791112	1068653	1065436		NC_000023.11:48791111:G:T
NM_002049.4(GATA1):c.485C>T (p.Ala162Val)	GATA1	A162V	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001054698	X	48650515	X	48792108	1054698	1052455		NC_000023.11:48792107:C:T
NM_002049.4(GATA1):c.1046T>C (p.Val349Ala)	GATA1	V349A	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV001047760	X	48652375	X	48793968	1047760	1035562		NC_000023.11:48793967:T:C
NM_002049.4(GATA1):c.821G>A (p.Ser274Asn)	GATA1	S274N	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|not provided	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV001044821	X	48651655	X	48793248	1044821	1035560		NC_000023.11:48793247:G:A
NM_002049.4(GATA1):c.595T>C (p.Cys199Arg)	GATA1	C199R	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV001043476	X	48650625	X	48792218	1043476	1035559		NC_000023.11:48792217:T:C
NM_002049.4(GATA1):c.889A>T (p.Met297Leu)	GATA1	M297L	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001043253	X	48652218	X	48793811	1043253	1035561		NC_000023.11:48793810:A:T
NM_002049.4(GATA1):c.1232T>C (p.Leu411Pro)	GATA1	L411P	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001025254	X	48652561	X	48794154	1025254	1014991		NC_000023.11:48794153:T:C
NM_002049.4(GATA1):c.145G>A (p.Ala49Thr)	GATA1	A49T	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001024740	X	48649661	X	48791254	1024740	1014988		NC_000023.11:48791253:G:A
NM_002049.4(GATA1):c.1067G>T (p.Gly356Val)	GATA1	G356V	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001021109	X	48652396	X	48793989	1021109	1014990		NC_000023.11:48793988:G:T
NM_002049.4(GATA1):c.283G>A (p.Gly95Ser)	GATA1	G95S	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001018362	X	48650313	X	48791906	1018362	1014989		NC_000023.11:48791905:G:A
NM_002049.4(GATA1):c.338G>T (p.Arg113Leu)	GATA1	R113L	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000999248	X	48650368	X	48791961	999248	999810		NC_000023.11:48791960:G:T
NM_002049.4(GATA1):c.950G>A (p.Arg317Gln)	GATA1	R317Q	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000970248	X	48652279	X	48793872	970248	959312		NC_000023.11:48793871:G:A
NM_002049.4(GATA1):c.220+1G>A	GATA1		Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000956466	X	48649737	X	48791330	956466	960386		NC_000023.11:48791329:G:A
NM_002049.4(GATA1):c.35C>G (p.Ser12Ter)	GATA1	S12*	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000952388	X	48649551	X	48791144	952388	929753		NC_000023.11:48791143:C:G
NM_002049.4(GATA1):c.337C>T (p.Arg113Cys)	GATA1	R113C	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000952347	X	48650367	X	48791960	952347	929755		NC_000023.11:48791959:C:T
NM_002049.4(GATA1):c.49C>T (p.Gln17Ter)	GATA1	Q17*	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000945515	X	48649565	X	48791158	945515	929754		NC_000023.11:48791157:C:T
NM_002049.4(GATA1):c.944A>G (p.Lys315Arg)	GATA1	K315R	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000945514	X	48652273	X	48793866	945514	929756		NC_000023.11:48793865:A:G
NM_002049.4(GATA1):c.266G>A (p.Gly89Glu)	GATA1	G89E	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000861781	X	48650296	X	48791889	861781	850107		NC_000023.11:48791888:G:A
NM_002049.4(GATA1):c.1024G>A (p.Gly342Ser)	GATA1	G342S	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000849725	X	48652353	X	48793946	849725	850108		NC_000023.11:48793945:G:A
NM_002049.4(GATA1):c.152G>A (p.Ser51Asn)	GATA1	S51N	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Uncertain significance(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000837426	X	48649668	X	48791261	837426	850106		NC_000023.11:48791260:G:A
NM_002049.4(GATA1):c.207C>T (p.Tyr69=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia|not provided	Likely benign(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000793730	X	48649723	X	48791316	793730	786853	rs1602219215	NC_000023.11:48791315:C:T
NM_002049.4(GATA1):c.282C>T (p.Ala94=)	GATA1		not provided|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Likely benign(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000774051	X	48650312	X	48791905	774051	706247	rs782123071	NC_000023.11:48791904:C:T
NM_002049.4(GATA1):c.150G>A (p.Pro50=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000767299	X	48649666	X	48791259	767299	706246	rs782678694	NC_000023.11:48791258:G:A
NM_002049.4(GATA1):c.744+5G>A	GATA1		not provided|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000705411	X	48650880	X	48792473	705411	695908	rs376546932	NC_000023.11:48792472:G:A
NM_002049.4(GATA1):c.870+8C>T	GATA1|LOC119407405		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Likely benign(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000705161	X	48651712	X	48793305	705161	695909	rs370706809	NC_000023.11:48793304:C:T
NM_002049.4(GATA1):c.942A>G (p.Lys314=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000700247	X	48652271	X	48793864	700247	689522	rs150473615	NC_000023.11:48793863:A:G
NM_002049.4(GATA1):c.361G>A (p.Val121Met)	GATA1	V121M	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000699558	X	48650391	X	48791984	699558	689519	rs200509606	NC_000023.11:48791983:G:A
NM_002049.4(GATA1):c.798G>A (p.Thr266=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Likely benign(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000699197	X	48651632	X	48793225	699197	689521	rs184692721	NC_000023.11:48793224:G:A
NM_002049.4(GATA1):c.1045G>A (p.Val349Met)	GATA1	V349M	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia|not provided	Benign/Likely benign(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000698888	X	48652374	X	48793967	698888	689523	rs199710067	NC_000023.11:48793966:G:A
NM_002049.4(GATA1):c.621C>T (p.Cys207=)	GATA1		not provided|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Likely benign(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000698740	X	48650752	X	48792345	698740	689520	rs782785151	NC_000023.11:48792344:C:T
NM_002049.4(GATA1):c.93G>T (p.Gly31=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000697339	X	48649609	X	48791202	697339	685017	rs368193049	NC_000023.11:48791201:G:T
NM_002049.4(GATA1):c.745-9G>A	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV000696788	X	48651570	X	48793163	696788	685490	rs371005242	NC_000023.11:48793162:G:A
NM_002049.4(GATA1):c.571C>T (p.Arg191Cys)	GATA1	R191C	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000696057	X	48650601	X	48792194	696057	685019	rs140561920	NC_000023.11:48792193:C:T
NM_002049.4(GATA1):c.201G>A (p.Glu67=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV000695994	X	48649717	X	48791310	695994	685018	rs61753429	NC_000023.11:48791309:G:A
NM_002049.4(GATA1):c.529G>A (p.Gly177Arg)	GATA1	G177R	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000573549	X	48650559	X	48792152	573549	574743	rs1482381233	NC_000023.11:48792151:G:A
NM_002049.4(GATA1):c.212A>G (p.His71Arg)	GATA1	H71R	GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000533696	X	48649728	X	48791321	533696	535006	rs374300356	NC_000023.11:48791320:A:G
NM_002049.4(GATA1):c.242T>C (p.Leu81Pro)	GATA1	L81P	not provided|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Likely benign(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000533693	X	48650272	X	48791865	533693	535010	rs1557020166	NC_000023.11:48791864:T:C
NM_002049.4(GATA1):c.94G>A (p.Val32Ile)	GATA1	V32I	Complete trisomy 21 syndrome|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis|Anemia without thromobocytopenia, X-linked|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2019)	criteria provided, conflicting interpretations	VCV000465135	X	48649610	X	48791203	465135	471610	rs782698349	NC_000023.11:48791202:G:A
NM_002049.4(GATA1):c.113C>T (p.Pro38Leu)	GATA1	P38L	not specified|Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign/Likely benign(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000435275	X	48649629	X	48791222	435275	430809	rs372131208	NC_000023.11:48791221:C:T
NM_002049.4(GATA1):c.479A>G (p.Asn160Ser)	GATA1	N160S	Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis	Benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000406678	X	48650509	X	48792102	406678	404264	rs59609788	NC_000023.11:48792101:A:G
NM_002049.4(GATA1):c.174G>A (p.Ala58=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia|not specified	Benign/Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000258542	X	48649690	X	48791283	258542	257847	rs139614533	NC_000023.11:48791282:G:A
NM_002049.4(GATA1):c.1173G>A (p.Thr391=)	GATA1		GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia|not specified	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000258541	X	48652502	X	48794095	258541	257848	rs61735969	NC_000023.11:48794094:G:A
NM_002049.4(GATA1):c.2T>C (p.Met1Thr)	GATA1	M1T	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|Anemia without thromobocytopenia, X-linked|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000156265	X	48649518	X	48791111	156265	166050	rs587776451	NC_000023.11:48791110:T:C
NM_002049.4(GATA1):c.163G>A (p.Ala55Thr)	GATA1	A55T	not provided|Diamond-Blackfan anemia|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|not specified	Benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000134462	X	48649679	X	48791272	134462	138201	rs150572851	NC_000023.11:48791271:G:A
NM_002049.4(GATA1):c.647G>A (p.Arg216Gln)	GATA1		not provided|GATA binding protein 1 related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia|Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000010428	X	48650778	X	48792371	10428	25467	rs104894809	NC_000023.11:48792370:G:A
NM_000410.4(HFE):c.187C>G (p.His63Asp)	HFE|HFE-AS1	H63D, H40D	not specified|Hemochromatosis type 1|Transferrin serum level quantitative trait locus 2|Familial porphyria cutanea tarda|Microvascular complications of diabetes 7|Variegate porphyria|Alzheimer disease|Hemochromatosis type 1|Microvascular complications of diabetes 7|not provided|Cystic fibrosis|Hereditary hemochromatosis|Bronze diabetes	Conflicting interpretations of pathogenicity, other(Last reviewed: Sep 15, 2021)	criteria provided, conflicting interpretations	VCV000000010	6	26091179	6	26090951	10	15049	rs1799945	NC_000006.12:26090950:C:G
NM_198129.4(LAMA3):c.8851C>T (p.Arg2951Cys)	LAMA3	R1342C, R2951C, R1286C, R2895C	Junctional epidermolysis bullosa gravis of Herlitz|Laryngo-onycho-cutaneous syndrome	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000555996	18	21513888	18	23933924	555996	548665	rs61752346	NC_000018.10:23933923:C:T
NM_198129.4(LAMA3):c.9512-11T>C	LAMA3		Laryngo-onycho-cutaneous syndrome|Junctional epidermolysis bullosa gravis of Herlitz	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000326345	18	21529982	18	23950018	326345	341206	rs776372744	NC_000018.10:23950017:T:C
NM_198129.4(LAMA3):c.9241C>T (p.Arg3081Cys)	LAMA3	R1472C, R3081C, R1416C, R3025C	not provided|Junctional epidermolysis bullosa gravis of Herlitz|Laryngo-onycho-cutaneous syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000326344	18	21526138	18	23946174	326344	341201	rs35762515	NC_000018.10:23946173:C:T
NM_198129.4(LAMA3):c.6616-13G>T	LAMA3		Laryngo-onycho-cutaneous syndrome|Junctional epidermolysis bullosa gravis of Herlitz	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000326311	18	21485473	18	23905509	326311	347999	rs886053672	NC_000018.10:23905508:G:T
NM_000093.5(COL5A1):c.4863G>T (p.Glu1621Asp)	LOC101448202|COL5A1	E1621D	Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420014	9	137716610	9	134824764	420014	407598	rs1064794238	NC_000009.12:134824763:G:T
NM_000093.5(COL5A1):c.5439G>T (p.Val1813=)	LOC101448202|COL5A1		Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome, type 7A	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2021)	criteria provided, conflicting interpretations	VCV000365736	9	137734071	9	134842225	365736	311738	rs886063678	NC_000009.12:134842224:G:T
NM_000093.5(COL5A1):c.4782C>T (p.Asp1594=)	LOC101448202|COL5A1		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype|not provided	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264439	9	137716529	9	134824683	264439	258555	rs372971566	NC_000009.12:134824682:C:T
NM_000093.5(COL5A1):c.5223C>T (p.Asn1741=)	LOC101448202|COL5A1		Ehlers-Danlos syndrome, classic type|Cardiovascular phenotype	Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000264007	9	137726903	9	134835057	264007	258558	rs144081161	NC_000009.12:134835056:C:T
NM_000093.5(COL5A1):c.4804G>A (p.Val1602Met)	LOC101448202|COL5A1	V1602M	Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|not provided	Uncertain significance(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000213058	9	137716551	9	134824705	213058	210124	rs201771867	NC_000009.12:134824704:G:A
NM_000093.5(COL5A1):c.5097C>G (p.Asn1699Lys)	LOC101448202|COL5A1	N1699K	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Uncertain significance(Last reviewed: Feb 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212997	9	137721851	9	134830005	212997	210136	rs138396959	NC_000009.12:134830004:C:G
NM_000093.5(COL5A1):c.4814C>T (p.Ala1605Val)	LOC101448202|COL5A1	A1605V	not provided|Cardiovascular phenotype|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Likely benign(Last reviewed: Apr 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212992	9	137716561	9	134824715	212992	210125	rs145175057	NC_000009.12:134824714:C:T
NM_000093.5(COL5A1):c.4658C>T (p.Pro1553Leu)	LOC101448202|COL5A1	P1553L	Cardiovascular phenotype|not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000212986	9	137715275	9	134823429	212986	210115	rs530570306	NC_000009.12:134823428:C:T
NM_000093.5(COL5A1):c.4652C>T (p.Thr1551Ile)	LOC101448202|COL5A1	T1551I	not provided|Ehlers-Danlos syndrome classic type 2|Ehlers-Danlos syndrome, classic type|Ehlers-Danlos syndrome, type 7A	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212985	9	137715269	9	134823423	212985	210114	rs863223460	NC_000009.12:134823422:C:T
NM_000093.5(COL5A1):c.4683A>C (p.Gly1561=)	LOC101448202|COL5A1		not specified|Ehlers-Danlos syndrome, type 7A|Ehlers-Danlos syndrome, classic type I|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136902	9	137715300	9	134823454	136902	140605	rs149959668	NC_000009.12:134823453:A:C
NM_005120.3(MED12):c.5476C>T (p.Pro1826Ser)	MED12	P1826S	Ehlers-Danlos syndrome, classic type|FG syndrome 1	Uncertain significance(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000492843	X	70356804	X	71136954	492843	485859	rs867576281	NC_000023.11:71136953:C:T
NM_001040108.2(MLH3):c.1387A>C (p.Ser463Arg)	MLH3	S463R	Hereditary nonpolyposis colorectal cancer type 7|Premature ovarian failure	Conflicting interpretations of pathogenicity(Last reviewed: Mar 2, 2020)	criteria provided, conflicting interpretations	VCV000836477	14	75514972	14	75048269	836477	841761		NC_000014.9:75048268:T:G
NM_000302.4(PLOD1):c.1533C>G (p.Tyr511Ter)	PLOD1	Y511*, Y558*	Ehlers-Danlos syndrome, hydroxylysine-deficient|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014370	1	12025599	1	11965542	14370	29409	rs121913552	NC_000001.11:11965541:C:G
NM_000303.3(PMM2):c.323C>T (p.Ala108Val)	PMM2	A108V	Congenital disorder of glycosylation, type Ia|not provided|Premature ovarian failure	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000092800	16	8900240	16	8806383	92800	98707	rs200503569	NC_000016.10:8806382:C:T
NM_058216.3(RAD51C):c.1090A>G (p.Ser364Gly)	RAD51C	S364G	Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group O|not provided|Premature ovarian failure	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2020)	criteria provided, conflicting interpretations	VCV000142585	17	56811542	17	58734181	142585	152299	rs587782565	NC_000017.11:58734180:A:G
NM_001319074.4(RAX2):c.131G>A (p.Arg44Gln)	RAX2	R44Q	Cone-rod dystrophy 11|Age-related macular degeneration 6	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000892560	19	3771610	19	3771612	892560	880411		NC_000019.10:3771611:C:T
NM_001319074.4(RAX2):c.134C>T (p.Ala45Val)	RAX2	A45V	not provided|Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000892559	19	3771607	19	3771609	892559	880410		NC_000019.10:3771608:G:A
NM_001319074.4(RAX2):c.446A>G (p.His149Arg)	RAX2	H149R	Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892495	19	3770728	19	3770730	892495	880406		NC_000019.10:3770729:T:C
NM_001319074.4(RAX2):c.535A>G (p.Arg179Gly)	RAX2	R179G	Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892494	19	3770639	19	3770641	892494	880405		NC_000019.10:3770640:T:C
NM_001319074.4(RAX2):c.*647T>C	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892439	19	3769972	19	3769974	892439	880396		NC_000019.10:3769973:A:G
NM_001319074.4(RAX2):c.*667G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892438	19	3769952	19	3769954	892438	880395		NC_000019.10:3769953:C:T
NM_001319074.4(RAX2):c.217-11G>C	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000891363	19	3770968	19	3770970	891363	880742		NC_000019.10:3770969:C:G
NM_001319074.4(RAX2):c.*194C>G	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891297	19	3770425	19	3770427	891297	880404		NC_000019.10:3770426:G:C
NM_001319074.4(RAX2):c.*195G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891296	19	3770424	19	3770426	891296	880403		NC_000019.10:3770425:C:T
NM_001319074.4(RAX2):c.*687A>G	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000891249	19	3769932	19	3769934	891249	880394		NC_000019.10:3769933:T:C
NM_001319074.4(RAX2):c.*751G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000891248	19	3769868	19	3769870	891248	880393		NC_000019.10:3769869:C:T
NM_001319074.4(RAX2):c.*1169G>A	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000891193	19	3769450	19	3769452	891193	880388		NC_000019.10:3769451:C:T
NM_001319074.4(RAX2):c.*1490A>G	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000890643	19	3769129	19	3769131	890643	880387		NC_000019.10:3769130:T:C
NM_001319074.4(RAX2):c.-275G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889884	19	3772167	19	3772169	889884	880413		NC_000019.10:3772168:C:T
NM_001319074.4(RAX2):c.*201C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889757	19	3770418	19	3770420	889757	880402		NC_000019.10:3770419:G:A
NM_001319074.4(RAX2):c.*248C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889756	19	3770371	19	3770373	889756	880401		NC_000019.10:3770372:G:A
NM_001319074.4(RAX2):c.*263C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000889755	19	3770356	19	3770358	889755	880400		NC_000019.10:3770357:G:A
NM_001319074.4(RAX2):c.*368C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889754	19	3770251	19	3770253	889754	880399		NC_000019.10:3770252:G:A
NM_001319074.4(RAX2):c.*776C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889691	19	3769843	19	3769845	889691	880392		NC_000019.10:3769844:G:A
NM_001319074.4(RAX2):c.*784C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889690	19	3769835	19	3769837	889690	880391		NC_000019.10:3769836:G:A
NM_001319074.4(RAX2):c.49G>C (p.Gly17Arg)	RAX2	G17R	Age-related macular degeneration 6|Cone-rod dystrophy 11	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000889200	19	3771692	19	3771694	889200	880412		NC_000019.10:3771693:C:G
NM_001319074.4(RAX2):c.320C>T (p.Pro107Leu)	RAX2	P107L	Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000889124	19	3770854	19	3770856	889124	880409		NC_000019.10:3770855:G:A
NM_001319074.4(RAX2):c.385G>A (p.Val129Met)	RAX2	V129M	not provided|Cone-rod dystrophy 11|Age-related macular degeneration 6	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)	criteria provided, conflicting interpretations	VCV000889123	19	3770789	19	3770791	889123	880408		NC_000019.10:3770790:C:T
NM_001319074.4(RAX2):c.413C>T (p.Pro138Leu)	RAX2	P138L	not provided|Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000889122	19	3770761	19	3770763	889122	880407		NC_000019.10:3770762:G:A
NM_001319074.4(RAX2):c.*501C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889063	19	3770118	19	3770120	889063	880398		NC_000019.10:3770119:G:A
NM_001319074.4(RAX2):c.*552C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000889062	19	3770067	19	3770069	889062	880397		NC_000019.10:3770068:G:A
NM_001319074.4(RAX2):c.*897C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000888998	19	3769722	19	3769724	888998	880390		NC_000019.10:3769723:G:A
NM_001319074.4(RAX2):c.*918G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000888997	19	3769701	19	3769703	888997	880389		NC_000019.10:3769702:C:T
NM_001319074.4(RAX2):c.-319C>A	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328978	19	3772211	19	3772213	328978	348679	rs886054371	NC_000019.10:3772212:G:T
NM_001319074.4(RAX2):c.-316G>A	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328977	19	3772208	19	3772210	328977	349735	rs576680324	NC_000019.10:3772209:C:T
NM_001319074.4(RAX2):c.-286G>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328976	19	3772178	19	3772180	328976	348678	rs563046576	NC_000019.10:3772179:C:A
NM_001319074.4(RAX2):c.-281G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328975	19	3772173	19	3772175	328975	343385	rs182965071	NC_000019.10:3772174:C:T
NM_001319074.4(RAX2):c.-270C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328974	19	3772162	19	3772164	328974	333284	rs776666200	NC_000019.10:3772163:G:A
NM_001319074.4(RAX2):c.-269+8C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328973	19	3772153	19	3772155	328973	343383	rs886054370	NC_000019.10:3772154:G:A
NM_001319074.4(RAX2):c.19G>A (p.Glu7Lys)	RAX2	E7K	Age-related macular degeneration 6|Cone-rod dystrophy 11	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000328972	19	3771722	19	3771724	328972	348675	rs556179949	NC_000019.10:3771723:C:T
NM_001319074.4(RAX2):c.76A>C (p.Lys26Gln)	RAX2	K26Q	Age-related macular degeneration 6|not provided|Cone-rod dystrophy 11	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2020)	criteria provided, conflicting interpretations	VCV000328971	19	3771665	19	3771667	328971	349732	rs370364475	NC_000019.10:3771666:T:G
NM_001319074.4(RAX2):c.83G>A (p.Arg28Gln)	RAX2	R28Q	Age-related macular degeneration 6|not provided|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000328970	19	3771658	19	3771660	328970	348673	rs199546013	NC_000019.10:3771659:C:T
NM_001319074.4(RAX2):c.156G>A (p.Pro52=)	RAX2		Age-related macular degeneration 6|not provided|Cone-rod dystrophy 11	Conflicting interpretations of pathogenicity(Last reviewed: Nov 26, 2020)	criteria provided, conflicting interpretations	VCV000328969	19	3771585	19	3771587	328969	343382	rs141804618	NC_000019.10:3771586:C:T
NM_001319074.4(RAX2):c.217-10C>T	RAX2		Age-related macular degeneration 6|not provided|Cone-rod dystrophy 11	Benign/Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000328968	19	3770967	19	3770969	328968	333283	rs772762463	NC_000019.10:3770968:G:A
NM_001319074.4(RAX2):c.217-8C>A	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328967	19	3770965	19	3770967	328967	348666	rs79588413	NC_000019.10:3770966:G:T
NM_001319074.4(RAX2):c.282C>T (p.Ala94=)	RAX2		Age-related macular degeneration 6|not provided|Cone-rod dystrophy 11	Benign/Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000328966	19	3770892	19	3770894	328966	349731	rs201021639	NC_000019.10:3770893:G:A
NM_001319074.4(RAX2):c.*7C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328965	19	3770612	19	3770614	328965	348665	rs781395665	NC_000019.10:3770613:G:A
NM_001319074.4(RAX2):c.*45C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328964	19	3770574	19	3770576	328964	343379	rs139146360	NC_000019.10:3770575:G:A
NM_001319074.4(RAX2):c.*88C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328963	19	3770531	19	3770533	328963	348664	rs886054369	NC_000019.10:3770532:G:A
NM_001319074.4(RAX2):c.*191C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328962	19	3770428	19	3770430	328962	348661	rs150808899	NC_000019.10:3770429:G:A
NM_001319074.4(RAX2):c.*381A>G	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328961	19	3770238	19	3770240	328961	343378	rs73531473	NC_000019.10:3770239:T:C
NM_001319074.4(RAX2):c.*624G>A	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328959	19	3769995	19	3769997	328959	333282	rs886054368	NC_000019.10:3769996:C:T
NM_001319074.4(RAX2):c.*679C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328958	19	3769940	19	3769942	328958	349729	rs576669713	NC_000019.10:3769941:G:A
NM_001319074.4(RAX2):c.*680G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328957	19	3769939	19	3769941	328957	349728	rs28673245	NC_000019.10:3769940:C:T
NM_001319074.4(RAX2):c.*689C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328956	19	3769930	19	3769932	328956	348659	rs115071988	NC_000019.10:3769931:G:A
NM_001319074.4(RAX2):c.*720G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328955	19	3769899	19	3769901	328955	348658	rs917547	NC_000019.10:3769900:C:T
NM_001319074.4(RAX2):c.*785G>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328953	19	3769834	19	3769836	328953	333278	rs917546	NC_000019.10:3769835:C:T
NM_001319074.4(RAX2):c.*866C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328952	19	3769753	19	3769755	328952	343371	rs917545	NC_000019.10:3769754:G:A
NM_001319074.4(RAX2):c.*902G>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328951	19	3769717	19	3769719	328951	343367	rs10405125	NC_000019.10:3769718:C:A
NM_001319074.4(RAX2):c.*949C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328950	19	3769670	19	3769672	328950	333277	rs886054367	NC_000019.10:3769671:G:A
NM_001319074.4(RAX2):c.*972T>A	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328949	19	3769647	19	3769649	328949	348651	rs886054366	NC_000019.10:3769648:A:T
NM_001319074.4(RAX2):c.*1054C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328948	19	3769565	19	3769567	328948	333275	rs368356816	NC_000019.10:3769566:G:A
NM_001319074.4(RAX2):c.*1149C>T	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328945	19	3769470	19	3769472	328945	348648	rs1860322	NC_000019.10:3769471:G:A
NM_001319074.4(RAX2):c.*1324A>G	RAX2		Cone-rod dystrophy 11|Age-related macular degeneration 6	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328943	19	3769295	19	3769297	328943	349722	rs138882802	NC_000019.10:3769296:T:C
NM_001319074.4(RAX2):c.*1366C>G	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328942	19	3769253	19	3769255	328942	349721	rs6510769	NC_000019.10:3769254:G:C
NM_001319074.4(RAX2):c.*1483C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000328941	19	3769136	19	3769138	328941	333267	rs886054363	NC_000019.10:3769137:G:A
NM_001319074.4(RAX2):c.*1523T>C	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000328940	19	3769096	19	3769098	328940	349718	rs775609621	NC_000019.10:3769097:A:G
NM_001319074.4(RAX2):c.432G>A (p.Ala144=)	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2020)	criteria provided, conflicting interpretations	VCV000262101	19	3770742	19	3770744	262101	256893	rs149918940	NC_000019.10:3770743:C:T
NM_001319074.4(RAX2):c.45T>G (p.Gly15=)	RAX2		not specified|Age-related macular degeneration 6|Cone-rod dystrophy 11|not provided	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195392	19	3771696	19	3771698	195392	192553	rs139127905	NC_000019.10:3771697:A:C
NM_001319074.4(RAX2):c.217-8C>T	RAX2		Age-related macular degeneration 6|Cone-rod dystrophy 11|not specified|not provided	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096230	19	3770965	19	3770967	96230	102124	rs79588413	NC_000019.10:3770966:G:A
NM_001319074.4(RAX2):c.155C>T (p.Pro52Leu)	RAX2	P52L	Age-related macular degeneration 6|Cone-rod dystrophy 11|not provided|not specified	Benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096229	19	3771586	19	3771588	96229	102123	rs76076446	NC_000019.10:3771587:G:A
NM_001319074.4(RAX2):c.260G>A (p.Arg87Gln)	RAX2	R87Q	Age-related macular degeneration 6|Cone-rod dystrophy 11|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2020)	criteria provided, conflicting interpretations	VCV000001240	19	3770914	19	3770916	1240	16279	rs121908280	NC_000019.10:3770915:C:T
NM_000295.4(SERPINA1):c.[1096G>A;35T>C]	SERPINA1	E366K, L12P	Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000626304	14|14	94844947	14|14	94378610	626304	33006|614641	rs28929474|rs1566759056	NC_000014.9:94378609:C:T|NC_000014.9:94383202:A:G
NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)	SERPINA1	E366K	PI Z(AUGSBURG)|PI Z(TUN)|Inborn genetic diseases|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|Chronic obstructive pulmonary disease|PI Z|not provided|FRAXE|Alpha-1-antitrypsin deficiency	Pathogenic, risk factor(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017967	14	94844947	14	94378610	17967	33006	rs28929474	NC_000014.9:94378609:C:T
NM_000371.4(TTR):c.148G>A (p.Val50Met)	TTR	V50M	none provided|Cardiomyopathy|Charcot-Marie-Tooth disease|not provided|Amyloidogenic transthyretin amyloidosis|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome|Amyloidogenic transthyretin amyloidosis	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013417	18	29172937	18	31592974	13417	28456	rs28933979	NC_000018.10:31592973:G:A
